Viewing Study NCT00090103

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:48 PM

Ignite Modification Date: 2026-03-10 @ 8:48 PM

Study NCT ID: NCT00090103

Status: COMPLETED

Last Update Posted: 2017-02-28

First Post: 2004-08-24

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D011470', 'term': 'Prostatic Hyperplasia'}], 'ancestors': [{'id': 'D011469', 'term': 'Prostatic Diseases'}, {'id': 'D005832', 'term': 'Genital Diseases, Male'}, {'id': 'D000091662', 'term': 'Genital Diseases'}, {'id': 'D000091642', 'term': 'Urogenital Diseases'}, {'id': 'D052801', 'term': 'Male Urogenital Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000068538', 'term': 'Dutasteride'}, {'id': 'D000077409', 'term': 'Tamsulosin'}], 'ancestors': [{'id': 'D001378', 'term': 'Azasteroids'}, {'id': 'D013260', 'term': 'Steroids, Heterocyclic'}, {'id': 'D013256', 'term': 'Steroids'}, {'id': 'D000072473', 'term': 'Fused-Ring Compounds'}, {'id': 'D011083', 'term': 'Polycyclic Compounds'}, {'id': 'D000096926', 'term': 'Benzenesulfonamides'}, {'id': 'D013449', 'term': 'Sulfonamides'}, {'id': 'D000577', 'term': 'Amides'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D001555', 'term': 'Benzene Derivatives'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D013450', 'term': 'Sulfones'}, {'id': 'D013457', 'term': 'Sulfur Compounds'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'phone': '866-435-7343', 'title': 'GSK Response Center', 'organization': 'GlaxoSmithKline'}, 'certainAgreement': {'otherDetails': 'GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.', 'restrictionType': 'OTHER', 'piSponsorEmployee': False, 'restrictiveAgreement': True}}, 'adverseEventsModule': {'eventGroups': [{'id': 'EG000', 'title': 'Combination', 'otherNumAtRisk': 1610, 'otherNumAffected': 618, 'seriousNumAtRisk': 1610, 'seriousNumAffected': 303}, {'id': 'EG001', 'title': 'Dutasteride 0.5 mg', 'otherNumAtRisk': 1623, 'otherNumAffected': 586, 'seriousNumAtRisk': 1623, 'seriousNumAffected': 339}, {'id': 'EG002', 'title': 'Tamsulosin 0.4 mg', 'otherNumAtRisk': 1611, 'otherNumAffected': 590, 'seriousNumAtRisk': 1611, 'seriousNumAffected': 348}], 'otherEvents': [{'term': 'Erectile dysfunction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 167}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 147}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 109}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 133}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 147}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 136}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nasopharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 134}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 129}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 149}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 107}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 88}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 113}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Influenza', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 77}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 75}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 83}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}], 'seriousEvents': [{'term': 'Myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 16}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 25}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 20}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 14}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 15}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Angina pectoris', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 14}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 14}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 15}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Atrial fibrillation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 7}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 9}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute myocardial infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 7}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 5}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Myocardial ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Angina unstable', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Supraventricular tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute coronary syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bradycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac failure congestive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sick sinus syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arrhythmia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Atrial flutter', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mitral valve incompetence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ventricular extrasystoles', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic valve incompetence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardio-respiratory arrest', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pericarditis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ventricular tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery insufficiency', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic valve disease mixed', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arteriosclerosis coronary artery', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Atrioventricular block', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Atrioventricular block complete', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'AV dissociation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac asthma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac failure chronic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery aneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coronary artery thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Left ventricular failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mitral valve prolapse', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tachycardia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tricuspid valve incompetence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiovascular deconditioning', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiopulmonary failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Congestive cardiomyopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypertensive cardiomyopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac valve disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute left ventricular failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chronic left ventricular failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostate cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 21}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 17}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 25}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colon cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 9}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 5}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lung neoplasm malignant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 5}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hepatic neoplasm malignant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lymphoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Malignant melanoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pancreatic carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rectal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder transitional cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastases to liver', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colon neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Myeloid leukaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Brain neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute myeloid leukaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Basal cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bronchial carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lung adenocarcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Oesophageal carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Thyroid neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pancreatic neolasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Adenocarcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Benign colonic neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder cancer recurrent', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Brain neoplasm benign', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Brain neoplasm malignant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Central nervous system lymphoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gallbladder cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastrointestinal carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Glioblastoma multiforme', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Laryngeal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Malignant neoplasm of ampulla of Vater', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Malignant palate neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mesothelioma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastases to bone', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastases to lung', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastatic pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Multiple myeloma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Neoplasm malignant', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Non-small cell lung cancer stage I', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pancreatic carcinoma metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostate cancer stage I', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Retinal melanoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Squamous cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tonsil cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tracheal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Transitional cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal oncocytoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary bladder adenoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastrointestinal cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hepatic cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colon cancer metastatic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Retroperitoneal neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Large intestine carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastases to central nervous system', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastatic neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary tract neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colorectal cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Salivary gland cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric neoplasm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Metastatic squamous cell carcinoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Thyroid cancer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder transitional cell carcinoma stage II', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder transitional cell carcinoma stage III', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebrovascular accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 11}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 15}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 8}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Transient ischaemic attack', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Syncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebral infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ischaemic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebral ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Carotid artery stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebral haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Convulsion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epilepsy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Grand mal convulsions', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Loss of consciousness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Balance disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': "Parkinson's disease", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Altered state of consciousness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Autonomic nervous system imbalance', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Brain stem ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': "Dementia Alzheimer's type", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dysarthria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Encephalopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Extrapyramidal disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemorrhage intracranial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hemiparesis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Monoplegia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Multiple sclerosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Neuritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Presyncope', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Psychomotor hyperactivity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sciatica', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Senile dementia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Somnolence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Thrombotic stroke', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Carotid artery occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intracranial hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lumbar radiculopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Radicular pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ischaemic cerebral infarction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebral cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nerve root compression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cerebral arteriosclerosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Inguinal hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 17}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 11}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abdominal pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colonic polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pancreatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pancreatitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abdominal hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemorrhoids', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ileus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rectal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abdominal pain upper', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anal fissure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Duodenal ulcer', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Duodenal ulcer haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric ulcer haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastrooesophageal reflux disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastrointestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Inguinal hernia, obstructive', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rectal polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abdominal distension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abdominal rigidity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anal fistula', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': "Barrett's oesophagus", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Colitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': "Crohn's disease", 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Diarrhoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Diverticulum', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Diverticulum intestinal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Duodenitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dysphagia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastric ulcer perforation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastritis haemorrhagic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haematemesis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haematochezia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Large intestine perforation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mallory-Weiss syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Melaena', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Oesophagitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peptic ulcer haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peritonitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Proctitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Small intestinal obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Umbilical hernia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Volvulus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vomiting', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lower gastrointestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mechanical ileus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pharyngoesophageal diverticulum', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intestinal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Appendix disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intra-abdominal haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bowel movement irregularity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Erosive oesophagitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anal prolapse', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Inguinal hernia strangulated', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 13}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 10}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 6}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urniary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cellulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bronchitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Diverticulitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lobar pneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urosepis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bronchopneumonia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Upper respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Appendicitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Septic shock', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Viral infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arthritis bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Respiratory tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Device related infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Abcess intestinal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Amoebiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bronchiectasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Carbuncle', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chronic sinusitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cystitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dengue fever', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ear infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Endocarditis bacterial', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epiglottitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gangrene', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastroenteritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastroenteritis Escherichia coli', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastroenteritis salmonella', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Infective myositis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Localised infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nasopharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Orchitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Osteomyelitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pneumonia streptococcal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostatic abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pyelonephritis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Salmonellosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Subcutaneous abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tinea pedis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Wound infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anal abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Streptococcal sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Postoperative abscess', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Escherichia urinary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Central line infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pseudomonal sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Implant site infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pseudomonas infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Biliary tract infection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epidemic nephropathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholecystitis infective', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cellulitis of male external genital organ', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Post procedural sepsis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gastroenteritis norovirus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Femur fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hip fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tibia fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Head injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Road traffic accident', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Subdural haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Tendon rupture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cartilage injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Fibula fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Multiple injuries', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rib fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Spinal fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cervical vertebral fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Contusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Post procedural haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Wound', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Concussion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Radius fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Spinal compression fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sternal fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ulna fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Wound dehiscence', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lumbar vertebral fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Accidental overdose', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ankle fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Carbon monoxide poisoning', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac pacemaker malfunction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Clavicle fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epicodylitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Extradural haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Fall', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Gun shot wound', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hand fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Muscle rupture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Patella fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Seroma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Wrist fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anaemia postoperative', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vascular pseudoaneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vascular graft occlusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Face injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Postoperative ileus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Device failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Medical device complicaiton', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Procedural complication', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Skin laceration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Traumatic brain injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Joint injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pelvic fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Limb injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lung injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Skull fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chest injury', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Upper limb fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Limb traumatic amputation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lower limb fracture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Procedural hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Post procedural haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Post procedural constipation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Osteoarthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 9}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 13}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 11}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intervertebral disc protrusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rotator cuff syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arthralgia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Spinal column stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Back pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Flank pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lumbar spinal stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cervical spinal stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Muscular weakness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Neck pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Osteoporosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Polymyalgia rheumatica', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Psoriatic arthropathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Rheumatoid arthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Spinal osteoarthritis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Musculoskeletal discomfort', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Foot deformity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intervertebral disc degeneration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nose deformity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Spondylolisthesis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary retention', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 15}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Calculus ureteric', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal failure acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Calculus bladder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nephrolithiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal colic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haematuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Calculus urinary', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dysuria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hydronephrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urine flow decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urethral stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder neck obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bladder obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Micturition disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nephrotic syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal failure chronic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary bladder haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary hesitation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary tract disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary bladder polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Ureteral polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Urinary tract obstruction', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Renal artery arteriosclerosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Renal and urinary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pulmonary embolism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 5}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dyspnoea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 5}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chronic obstructive pulmonary disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypoxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nasal polyps', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pleural effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 6}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pneumothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pulmonary oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sleep apnoea syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemoptysis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pneumonia aspiration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Respiratory failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute pulmonary oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Acute respiratory failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Asphyxia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemothorax', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Idioipathic pulmonary fibrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lung disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Nasal septum deviation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pleurisy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pulmonary hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sinus polyp', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Allergic granulomatous angiitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Asthmatic crisis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bronchial hyperreactivity', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 8}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic aneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic aneurysm rupture', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic dissection', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arteriosclerosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Circulatory collapse', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peripheral ischaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peripheral vascular disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Varicose vein', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Deep vein thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peripheral artery aneurysm', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Peripheral arterial occlusive disease', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypertensive crisis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Malignant hypertension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Orthostatic hypotension', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Thrombophlebitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Venous thrombosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Venous stenosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arterial stenosis limb', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic dilatation', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aortic disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arterial disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholelithiasis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 4}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 6}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 6}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholecystitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 3}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholecystitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bile duct stone', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholecystitis chronic', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Jaundice', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholangitis acute', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hepatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hydrocholecystis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hepatic mass', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Hepatobiliary disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pyrexia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 3}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Non-cardiac chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 4}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chest pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Multi-organ failure', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Asthenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Fatigue', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Generalised oedema', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Local swelling', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Malaise', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sudden death', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Implant site erosion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Benign prostatic hyperplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 10}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostatitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epididymal cyst', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Epididymitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Priapism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostatic intraepithelial neoplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostatism', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Reproductive system and breast disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cataract', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 4}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Retinal detachment', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Macular degeneration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Eye haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Glaucoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Retinal tear', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vitreous haemorrhage', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Eye disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Dehydration', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 3}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hyponatraemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Diabetes mellitus inadequate control', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hypercalcaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hyperkalaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Metabolism and nutrition disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Depression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anxiety', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Completed suicide', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Bipolar disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aggression', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Confusional state', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Delirium', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Mental status changes', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Granulocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Haemolytic anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Idiopathic thrombocytopenic purpura', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Lymphadenopathy', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pernicious anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Thrombocytopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Alanine aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aspartate aminotransferase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Chest x-ray abnormal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Coagulation factor decreased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Electrocardiogram abnormal', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Heart rate irregular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Intraocular pressure increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Prostatic specific antigen increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Blood alkaline phosphatase increased', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Investigations', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hydrocele', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Aplasia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hereditary sideroblastic anaemia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Congenital, familial and genetic disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Deafness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vertigo', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Vestibular disorder', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Sudden hearing loss', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Ear and labyrinth disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Hyperhidrosis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Purpura senile', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Stevens-Johnson syndrome', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Goitre', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Endocrine disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Pericardial effusion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cardiac tamponade', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Cholesteatoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Neoplasms benign, malignant and unspecified (incl cysts and polyps)', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Traumatic haematoma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Injury, poisoning and procedural complications', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Asthma', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 2}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 2}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Arteriovenous fistula', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 1}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}, {'term': 'Phlebitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 1610, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 1623, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 1611, 'numAffected': 0}], 'organSystem': 'Vascular disorders', 'assessmentType': 'SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA'}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Number of Events of Acute Urinary Retention (AUR) or Benign Prostatic Hyperplasia (BPH)-Related Prostatic Surgery at the Indicated Time Periods.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Year 1, n=1610, 1623, 1611', 'categories': [{'measurements': [{'value': '29', 'groupId': 'OG000'}, {'value': '27', 'groupId': 'OG001'}, {'value': '40', 'groupId': 'OG002'}]}]}, {'title': 'Year 2, n=1457, 1484, 1464', 'categories': [{'measurements': [{'value': '14', 'groupId': 'OG000'}, {'value': '22', 'groupId': 'OG001'}, {'value': '62', 'groupId': 'OG002'}]}]}, {'title': 'Year 3, n=1347, 1365, 1307', 'categories': [{'measurements': [{'value': '15', 'groupId': 'OG000'}, {'value': '16', 'groupId': 'OG001'}, {'value': '44', 'groupId': 'OG002'}]}]}, {'title': 'Year 4, n=1274, 1277, 1176', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '19', 'groupId': 'OG001'}, {'value': '45', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.18', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Relative Risk Estimate', 'ciPctValue': '95', 'paramValue': '0.80', 'ciLowerLimit': '0.58', 'ciUpperLimit': '1.11', 'pValueComment': 'Log-rank test with stratification by cluster.', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}, {'pValue': '<0.001', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Relative Risk Estimate', 'ciPctValue': '95', 'paramValue': '0.34', 'ciLowerLimit': '0.26', 'ciUpperLimit': '0.45', 'pValueComment': 'Log-rank test with stratification by cluster.', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Years 1, 2, 3, and 4', 'description': "A participant was considered to have AUR when he was unable to urinate and required bladder catheterization. BPH is also known as an enlarged prostate. When symptoms of BPH become bothersome, surgery may be required. When events of AUR and BPH-related surgery were participant-reported or identified, they were recorded in the participants' clinic record.", 'unitOfMeasure': 'events', 'reportingStatus': 'POSTED', 'populationDescription': 'Intent-to-Treat (ITT) Population: all participants randomized to the double-blind treatment period. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of Events of First BPH Clinical Progression at Years 1, 2, 3 and 4', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Year 1, n=1610, 1623, 1611', 'categories': [{'measurements': [{'value': '126', 'groupId': 'OG000'}, {'value': '184', 'groupId': 'OG001'}, {'value': '171', 'groupId': 'OG002'}]}]}, {'title': 'Year 2, n= 1264, 1240, 1262', 'categories': [{'measurements': [{'value': '31', 'groupId': 'OG000'}, {'value': '54', 'groupId': 'OG001'}, {'value': '78', 'groupId': 'OG002'}]}]}, {'title': 'Year 3, n=1135, 1082, 1048', 'categories': [{'measurements': [{'value': '30', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}, {'value': '67', 'groupId': 'OG002'}]}]}, {'title': 'Year 4, n= 1047, 959, 880', 'categories': [{'measurements': [{'value': '16', 'groupId': 'OG000'}, {'value': '22', 'groupId': 'OG001'}, {'value': '31', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Years 1, 2, 3, and 4', 'description': "The time when the first symptom/event of BPH clinical progression has occurred (i.e. AUR, incontinence) was measured. Summaries are based on the first occuring event after treatment start. The time period is from treatment start to each participant's last treatment visit. The Year 4 events include all those that occur during the fourth year and beyond.", 'unitOfMeasure': 'events', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'PRIMARY', 'title': 'Number of Participants With AUR or BPH-related Surgery', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'AUR', 'categories': [{'measurements': [{'value': '35', 'groupId': 'OG000'}, {'value': '44', 'groupId': 'OG001'}, {'value': '109', 'groupId': 'OG002'}]}]}, {'title': 'BPH-related surgery', 'categories': [{'measurements': [{'value': '32', 'groupId': 'OG000'}, {'value': '40', 'groupId': 'OG001'}, {'value': '82', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.18', 'groupIds': ['OG000', 'OG001'], 'ciPctValue': '95', 'pValueComment': 'Log rank test with stratification by cluster.', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}, {'pValue': '<0.001', 'groupIds': ['OG000', 'OG002'], 'ciPctValue': '95', 'pValueComment': 'Log rank test with stratification by cluster.', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': "A participant was considered to have AUR when he was unable to urinate and required bladder catheterization. BPH is also known as an enlarged prostate. When symptoms of BPH become bothersome, surgery may be required. When events of AUR and BPH-related surgery were participant reported or identified, they were recorded in the participants' clinic record.", 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population'}, {'type': 'SECONDARY', 'title': 'The Number of Participants With Each of the Five Components of BPH Clinical Progression', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Symptom deterioration', 'categories': [{'measurements': [{'value': '132', 'groupId': 'OG000'}, {'value': '203', 'groupId': 'OG001'}, {'value': '221', 'groupId': 'OG002'}]}]}, {'title': 'BPH-related AUR', 'categories': [{'measurements': [{'value': '22', 'groupId': 'OG000'}, {'value': '31', 'groupId': 'OG001'}, {'value': '64', 'groupId': 'OG002'}]}]}, {'title': 'BPH-related incontinence', 'categories': [{'measurements': [{'value': '46', 'groupId': 'OG000'}, {'value': '49', 'groupId': 'OG001'}, {'value': '56', 'groupId': 'OG002'}]}]}, {'title': 'Recurrent BPH-related UTI', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'BPH-related renal insufficiency', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline (Day 1) to Year 4', 'description': 'The five components measured were symptom deterioration, BPH-related AUR, BPH-related incontinence, recurrent BPH-related Urinary Tract Infection (UTI), and BPH-related renal insufficiency.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population'}, {'type': 'SECONDARY', 'title': 'Number of Events of Symptom Deterioration at the Indicated Time Periods', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Year 1, n=1610, 1623, 1611', 'categories': [{'measurements': [{'value': '91', 'groupId': 'OG000'}, {'value': '138', 'groupId': 'OG001'}, {'value': '119', 'groupId': 'OG002'}]}]}, {'title': 'Year 2, n=1286, 1278, 1296', 'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000'}, {'value': '38', 'groupId': 'OG001'}, {'value': '49', 'groupId': 'OG002'}]}]}, {'title': 'Year 3, n=1158, 1132, 1088', 'categories': [{'measurements': [{'value': '14', 'groupId': 'OG000'}, {'value': '23', 'groupId': 'OG001'}, {'value': '42', 'groupId': 'OG002'}]}]}, {'title': 'Year 4, n=1083, 1001, 926', 'categories': [{'measurements': [{'value': '11', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '19', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '<0.001', 'groupIds': ['OG000', 'OG001'], 'paramType': 'Relative Risk Estimate', 'ciPctValue': '95', 'paramValue': '0.65', 'ciLowerLimit': '0.52', 'ciUpperLimit': '0.80', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Log-rank test with stratification by cluster.', 'testedNonInferiority': False}, {'pValue': '<0.001', 'groupIds': ['OG000', 'OG002'], 'paramType': 'Relative Risk Estimate', 'ciPctValue': '95', 'paramValue': '0.59', 'ciLowerLimit': '0.48', 'ciUpperLimit': '0.72', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': "Years 1, 2, 3, and 4 (from treatment start until each participant's last treatment-phase visit)", 'description': 'The number of participants (par.) with symptom deterioration of International Prostate Symptom Score (IPSS) ≥4 points on two consecutive visits post-baseline are presented. Data are based on the first occurrence of an event after treatment start. The year-4 events include all that occured during the 4th year and beyond. The IPSS is a 7-item questionnaire measuring the level of urinary symptoms reported as the total score. Each question has a 6-point response scale (0=none/not at all to 5=almost always), with a total score ranging from 0-35: mild (0-7), moderate (8-19), or severe (20-35).', 'unitOfMeasure': 'events', 'reportingStatus': 'POSTED', 'populationDescription': 'Intent-to-Treat (ITT) Population: all participants randomized to the double-blind treatment period. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of Participants With an Event of Post-baseline BPH-related Macroscopic Hematuria', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Overall crude rate', 'categories': [{'measurements': [{'value': '53', 'groupId': 'OG000'}, {'value': '70', 'groupId': 'OG001'}, {'value': '81', 'groupId': 'OG002'}]}]}, {'title': 'Non-BPH-related Crude Rate', 'categories': [{'measurements': [{'value': '15', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '25', 'groupId': 'OG002'}]}]}, {'title': 'BPH-Related Crude Rate', 'categories': [{'measurements': [{'value': '40', 'groupId': 'OG000'}, {'value': '45', 'groupId': 'OG001'}, {'value': '56', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.65', 'groupIds': ['OG000', 'OG001'], 'ciPctValue': '95', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Mantel-Haenszel test with stratification by cluster.', 'testedNonInferiority': False}, {'pValue': '0.10', 'groupIds': ['OG000', 'OG002'], 'ciPctValue': '95', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Mantel-Hanenszel test with stratification by cluster.', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': 'A participant was considered to have macroscopic hematuria when there was presence of blood in the urine. The event of macroscopic hematuria was either participant-reported or identified by the investigator during a clinic visit. Overall Crude Rate is the number of participants from the total number analyzed that experience experienced an incident of post-baseline BPH or Non-BPH related macroscopic hematuria. Participants may appear in both categories.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population'}, {'type': 'SECONDARY', 'title': 'Number of Participants With an Event of Post-baseline BPH-related Hematospermia', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'OG000'}, {'value': '1623', 'groupId': 'OG001'}, {'value': '1611', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Overall Crude Rate', 'categories': [{'measurements': [{'value': '18', 'groupId': 'OG000'}, {'value': '19', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}]}, {'title': 'Non-BPH-related Crude Rate', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'BPH-related Crude Rate', 'categories': [{'measurements': [{'value': '17', 'groupId': 'OG000'}, {'value': '17', 'groupId': 'OG001'}, {'value': '11', 'groupId': 'OG002'}]}]}], 'analyses': [{'pValue': '0.95', 'groupIds': ['OG000', 'OG001'], 'ciPctValue': '95', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Mantel-Haenszel test with stratification by cluster.', 'testedNonInferiority': False}, {'pValue': '0.24', 'groupIds': ['OG000', 'OG002'], 'ciPctValue': '95', 'statisticalMethod': 'Log Rank', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'statisticalComment': 'Mantel-Haenszel test with stratification by cluster.', 'testedNonInferiority': False}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': 'A participant was considered to have hematospermia when there was presence of blood in the semen. Hematospermia can occur from prostatitis (prostate infection), from cancer, or after a prostate biopsy. The event of hematospermia was either participant-reported or identified by the investigator during a clinic visit. Overall Crude Rate is the number of participants from the total number analyzed that experience experienced an incident of post-baseline BPH or Non-BPH related hematospermia. Participants may appear in both categories.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Change From Baseline in International Prostate Symptom Score (IPSS) at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1575', 'groupId': 'OG000'}, {'value': '1592', 'groupId': 'OG001'}, {'value': '1582', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12', 'categories': [{'measurements': [{'value': '-5.6', 'spread': '0.15', 'groupId': 'OG000'}, {'value': '-4.2', 'spread': '0.15', 'groupId': 'OG001'}, {'value': '-4.5', 'spread': '0.15', 'groupId': 'OG002'}]}]}, {'title': 'Month 24', 'categories': [{'measurements': [{'value': '-6.2', 'spread': '0.15', 'groupId': 'OG000'}, {'value': '-4.9', 'spread': '0.15', 'groupId': 'OG001'}, {'value': '-4.3', 'spread': '0.15', 'groupId': 'OG002'}]}]}, {'title': 'Month 36', 'categories': [{'measurements': [{'value': '-6.3', 'spread': '0.16', 'groupId': 'OG000'}, {'value': '-5.2', 'spread': '0.16', 'groupId': 'OG001'}, {'value': '-4.0', 'spread': '0.16', 'groupId': 'OG002'}]}]}, {'title': 'Month 48', 'categories': [{'measurements': [{'value': '-6.3', 'spread': '0.16', 'groupId': 'OG000'}, {'value': '-5.3', 'spread': '0.16', 'groupId': 'OG001'}, {'value': '-3.8', 'spread': '0.16', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'The IPSS is a 7-item questionnaire that measures urinary symptoms. It measures the level of urinary symptoms (including incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia) reported as the total IPSS score. Each of the 7 questions has a 6-point response scale (0=none/not at all to 5=almost always) with a total score that can range from 0-35: mild (0-7), moderate (8-19), or severe (20-35). Estimates are based on adjusted (least squares) means from the general linear model: change from baseline IPSS = Treatment + Cluster + Baseline IPSS.', 'unitOfMeasure': 'points on a scale', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Change From Baseline in Urinary Flow Rate (Qmax) at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1495', 'groupId': 'OG000'}, {'value': '1505', 'groupId': 'OG001'}, {'value': '1523', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12, n=1477, 1482, 1510', 'categories': [{'measurements': [{'value': '2.0', 'spread': '0.12', 'groupId': 'OG000'}, {'value': '1.5', 'spread': '0.12', 'groupId': 'OG001'}, {'value': '0.9', 'spread': '0.12', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n= 1492, 1501, 1519', 'categories': [{'measurements': [{'value': '2.4', 'spread': '0.12', 'groupId': 'OG000'}, {'value': '1.9', 'spread': '0.12', 'groupId': 'OG001'}, {'value': '0.9', 'spread': '0.12', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n= 1495, 1504, 1521', 'categories': [{'measurements': [{'value': '2.6', 'spread': '0.12', 'groupId': 'OG000'}, {'value': '1.9', 'spread': '0.12', 'groupId': 'OG001'}, {'value': '0.6', 'spread': '0.12', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n= 1495, 1505, 1523', 'categories': [{'measurements': [{'value': '2.4', 'spread': '0.13', 'groupId': 'OG000'}, {'value': '2.0', 'spread': '0.13', 'groupId': 'OG001'}, {'value': '0.7', 'spread': '0.13', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Peak maximum urinary flow (Qmax) of urinary flow using a Medtronic (formerly Dantec) Uroflow Meter (Urodyn 1000 or Duet models) with a Thompson filter was measured. Estimates are based on adjusted (least squares) means from the general linear model: Change from baseline Qmax = treatment + cluster + baseline Qmax.', 'unitOfMeasure': 'milliliters (mL)/second (sec)', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Also, assessments with voided volumes \\<125 ml were not included in the analysis.'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Percent Change From Baseline in Prostate Volume at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1430', 'groupId': 'OG000'}, {'value': '1455', 'groupId': 'OG001'}, {'value': '1468', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12, n=1411, 1442, 1451', 'categories': [{'measurements': [{'value': '-24.1', 'spread': '0.60', 'groupId': 'OG000'}, {'value': '-25.2', 'spread': '0.59', 'groupId': 'OG001'}, {'value': '-1.5', 'spread': '0.77', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n= 1427, 1451, 1465', 'categories': [{'measurements': [{'value': '-26.9', 'spread': '0.62', 'groupId': 'OG000'}, {'value': '-28.0', 'spread': '0.61', 'groupId': 'OG001'}, {'value': '0.0', 'spread': '0.84', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n= 1430, 1455, 1468', 'categories': [{'measurements': [{'value': '-27.6', 'spread': '0.68', 'groupId': 'OG000'}, {'value': '-28.8', 'spread': '0.66', 'groupId': 'OG001'}, {'value': '1.6', 'spread': '0.94', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n= 1430, 1455, 1468', 'categories': [{'measurements': [{'value': '-27.3', 'spread': '0.66', 'groupId': 'OG000'}, {'value': '-28.0', 'spread': '0.65', 'groupId': 'OG001'}, {'value': '4.6', 'spread': '0.94', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Prostate volume measurements were conducted annually using Transurethral ultrasound (TRUS). The anteroposterior, cephalocaudal, and transverse diameters of the prostate obtained by TRUS calculate the total prostate volume centimeters (cc). Percent change from baseline = \\[(post-baseline - baseline)/baseline value\\] x 100. Estimates were based on the adjusted (least squares) means from the general linear model: log(post-baseline/baseline value) + treatment + cluster + log(baseline value) and are reported as percent change from baseline.', 'unitOfMeasure': 'percent change', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Also, prostate measurements were either not performed or missing for some participants at various timepoints.'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Change From Baseline in Transition Zone (Portion of the Prostate That Surrounds the Proximal Urethra) Volume at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '155', 'groupId': 'OG000'}, {'value': '164', 'groupId': 'OG001'}, {'value': '163', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12, n= 150, 159, 160', 'categories': [{'measurements': [{'value': '-17.2', 'spread': '3.29', 'groupId': 'OG000'}, {'value': '-15.6', 'spread': '3.39', 'groupId': 'OG001'}, {'value': '5.6', 'spread': '4.09', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n= 153, 164, 160', 'categories': [{'measurements': [{'value': '-23.4', 'spread': '5.63', 'groupId': 'OG000'}, {'value': '-22.8', 'spread': '5.86', 'groupId': 'OG001'}, {'value': '8.7', 'spread': '8.22', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n= 155, 164, 162', 'categories': [{'measurements': [{'value': '-20.9', 'spread': '3.97', 'groupId': 'OG000'}, {'value': '-26.7', 'spread': '3.90', 'groupId': 'OG001'}, {'value': '14.7', 'spread': '5.89', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n= 155, 164, 163', 'categories': [{'measurements': [{'value': '-17.9', 'spread': '4.45', 'groupId': 'OG000'}, {'value': '-26.5', 'spread': '4.21', 'groupId': 'OG001'}, {'value': '18.2', 'spread': '6.54', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Prostate volume (PV) measurements were conducted annually using Transurethral ultrasound (TRUS). The anteroposterior, cephalocaudal, and transverse diameters of the prostate obtained by TRUS calculate the total PV in centimeters (cc). Results are for the transition zone measurements of the prostate in a small subset of participants. Percent change from baseline (BL) = \\[(post-BL - BL)/BL value\\] x 100. Estimates are based on the adjusted (least squares) means for the general linear model: log(post-BL/BL value) = treatment + cluster + log(BL value) and are reported as percent change from BL.', 'unitOfMeasure': 'percent change', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Transition zone measurements were only done on a subset of participants at sites with experience in measuring the transition zone of the prostate. Also, transition zone measurements were either not performed or missing for some participants at various timepoints.'}, {'type': 'SECONDARY', 'title': 'Number of Unscheduled Visits to GP/Urologist Regarding AUR Symptoms Since the Last Study Visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1565', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1565', 'categories': [{'measurements': [{'value': '8', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1517, 1514', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1439, 1465, 1477', 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1380', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '10', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1166', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1035', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with an episode of AUR. Responses to the following question were recorded: "Has the participant needed to make any unscheduled visits to his general practitioner (GP)/Urologist regarding AUR symptoms since the last study visit?" If the answer to the question was "yes," the number of visits was recorded.', 'unitOfMeasure': 'visits', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of "Yes" Responses to the Question: "Would the Participant Have Paid a Visit to His GP/Urologist Regarding AUR Symptoms if the Study Visit Had Not Been Planned"?.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1564', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1564', 'categories': [{'measurements': [{'value': '31', 'groupId': 'OG000'}, {'value': '32', 'groupId': 'OG001'}, {'value': '29', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1516, 1513', 'categories': [{'measurements': [{'value': '21', 'groupId': 'OG000'}, {'value': '26', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1439, 1465, 1477', 'categories': [{'measurements': [{'value': '18', 'groupId': 'OG000'}, {'value': '14', 'groupId': 'OG001'}, {'value': '18', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '8', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1380', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '12', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '17', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '19', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '17', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '11', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1166', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '10', 'groupId': 'OG001'}, {'value': '11', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1035', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with an episode of AUR. Responses to the following question were recorded: "Would the participant have paid a visit to his GP/Urologist regarding AUR symptoms if this study visit had not been planned?". If the answer to the question was "yes," the number of Yes responses was recorded.', 'unitOfMeasure': 'yes responses', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of Visits to GP/Urologist Regarding BPH-related Surgery Since the Last Study Visit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1564', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1564', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1517, 1514', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1439, 1465, 1477', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1380', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1165', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '1', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1035', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '0', 'groupId': 'OG000'}, {'value': '2', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with BPH-related surgery. Responses to the following question were recorded: "Has the participant needed to visit his general practitioner (GP)/Urologist regarding BPH-related surgery since the last study visit?". If the answer to the question was "yes," the number of visits was recorded.', 'unitOfMeasure': 'visits', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of "Yes" Responses to the Question: "Would the Participant Have Paid a Visit to His GP/Urologist Regarding BPH-related Surgery Since the Last Study Visit?"', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1564', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1564', 'categories': [{'measurements': [{'value': '16', 'groupId': 'OG000'}, {'value': '34', 'groupId': 'OG001'}, {'value': '28', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1516, 1513', 'categories': [{'measurements': [{'value': '20', 'groupId': 'OG000'}, {'value': '23', 'groupId': 'OG001'}, {'value': '16', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1438, 1465, 1477', 'categories': [{'measurements': [{'value': '12', 'groupId': 'OG000'}, {'value': '10', 'groupId': 'OG001'}, {'value': '17', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '10', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1380', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '9', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '13', 'groupId': 'OG000'}, {'value': '12', 'groupId': 'OG001'}, {'value': '10', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '10', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}, {'value': '3', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1166', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '4', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1034', 'categories': [{'measurements': [{'value': '9', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '2', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '1', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with BPH-related surgery. Responses to the following question were recorded: "Would the participant have paid a visit to his general practitioner (GP)/Urologist regarding BPH-related surgery since the last study visit?". If the answer to the question was "yes," the number of Yes responses was recorded.', 'unitOfMeasure': 'yes responses', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As study progressed, participants dropped out of study.'}, {'type': 'SECONDARY', 'title': 'Number of Unplanned Visits to GP/Urologist That Would Have Taken Place if a Scheduled Study Visit Had Not Been Planned (Including Visits Resulting From UTI, UI, Macroscopic Haematuria, Etc.)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1564', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1564', 'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000'}, {'value': '25', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1517, 1514', 'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000'}, {'value': '34', 'groupId': 'OG001'}, {'value': '22', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1439, 1465, 1477', 'categories': [{'measurements': [{'value': '16', 'groupId': 'OG000'}, {'value': '35', 'groupId': 'OG001'}, {'value': '22', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '30', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}, {'value': '34', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1380', 'categories': [{'measurements': [{'value': '24', 'groupId': 'OG000'}, {'value': '22', 'groupId': 'OG001'}, {'value': '27', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '21', 'groupId': 'OG000'}, {'value': '25', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '18', 'groupId': 'OG000'}, {'value': '21', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '10', 'groupId': 'OG000'}, {'value': '19', 'groupId': 'OG001'}, {'value': '21', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '15', 'groupId': 'OG000'}, {'value': '11', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1166', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '10', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '10', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '7', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '19', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1035', 'categories': [{'measurements': [{'value': '4', 'groupId': 'OG000'}, {'value': '8', 'groupId': 'OG001'}, {'value': '12', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '3', 'groupId': 'OG000'}, {'value': '5', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '1', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with unplanned visits to GP/Urologist. Responses to the following question were recorded: "Has the participant had any unplanned GP/Urologist (outpatient) visits that would have taken place if a scheduled study visit had not been planned (this can include visits resulting from UTI, UI macroscopic haematuria, etc?". If the answer to the question was "yes," the number of visits was recorded.', 'unitOfMeasure': 'visits', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Number of Unscheduled Visits to GP/Urologist (Outpatient) Planned, Not Relating to the Study (Including Visits Resulting From UTI, UI, Macroscopic Haematuria, Etc.)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1550', 'groupId': 'OG000'}, {'value': '1581', 'groupId': 'OG001'}, {'value': '1564', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 3, n=1550, 1581, 1564', 'categories': [{'measurements': [{'value': '27', 'groupId': 'OG000'}, {'value': '27', 'groupId': 'OG001'}, {'value': '30', 'groupId': 'OG002'}]}]}, {'title': 'Month 6, n=1479, 1516, 1514', 'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000'}, {'value': '29', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}]}]}, {'title': 'Month 9, n=1439, 1465, 1477', 'categories': [{'measurements': [{'value': '12', 'groupId': 'OG000'}, {'value': '27', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, n=1400, 1431, 1434', 'categories': [{'measurements': [{'value': '30', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '29', 'groupId': 'OG002'}]}]}, {'title': 'Month 15, n=1343, 1386, 1381', 'categories': [{'measurements': [{'value': '19', 'groupId': 'OG000'}, {'value': '28', 'groupId': 'OG001'}, {'value': '32', 'groupId': 'OG002'}]}]}, {'title': 'Month 18, n=1318, 1350, 1328', 'categories': [{'measurements': [{'value': '23', 'groupId': 'OG000'}, {'value': '21', 'groupId': 'OG001'}, {'value': '34', 'groupId': 'OG002'}]}]}, {'title': 'Month 21, n=1281, 1326, 1287', 'categories': [{'measurements': [{'value': '20', 'groupId': 'OG000'}, {'value': '27', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, n=1263, 1293, 1244', 'categories': [{'measurements': [{'value': '29', 'groupId': 'OG000'}, {'value': '23', 'groupId': 'OG001'}, {'value': '26', 'groupId': 'OG002'}]}]}, {'title': 'Month 27, n=1233, 1262, 1206', 'categories': [{'measurements': [{'value': '13', 'groupId': 'OG000'}, {'value': '12', 'groupId': 'OG001'}, {'value': '16', 'groupId': 'OG002'}]}]}, {'title': 'Month 30, n=1222, 1221, 1166', 'categories': [{'measurements': [{'value': '10', 'groupId': 'OG000'}, {'value': '16', 'groupId': 'OG001'}, {'value': '10', 'groupId': 'OG002'}]}]}, {'title': 'Month 33, n=1202, 1199, 1128', 'categories': [{'measurements': [{'value': '6', 'groupId': 'OG000'}, {'value': '13', 'groupId': 'OG001'}, {'value': '20', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, n=1187, 1174, 1095', 'categories': [{'measurements': [{'value': '8', 'groupId': 'OG000'}, {'value': '12', 'groupId': 'OG001'}, {'value': '18', 'groupId': 'OG002'}]}]}, {'title': 'Month 39, n=1160, 1144, 1055', 'categories': [{'measurements': [{'value': '12', 'groupId': 'OG000'}, {'value': '10', 'groupId': 'OG001'}, {'value': '18', 'groupId': 'OG002'}]}]}, {'title': 'Month 42, n=1149, 1126, 1035', 'categories': [{'measurements': [{'value': '15', 'groupId': 'OG000'}, {'value': '9', 'groupId': 'OG001'}, {'value': '15', 'groupId': 'OG002'}]}]}, {'title': 'Month 45, n=1129, 1110, 1009', 'categories': [{'measurements': [{'value': '5', 'groupId': 'OG000'}, {'value': '7', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, n=1113, 1093, 990', 'categories': [{'measurements': [{'value': '7', 'groupId': 'OG000'}, {'value': '4', 'groupId': 'OG001'}, {'value': '8', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with unplanned visits to GP/Urologist. Responses to the following question were recorded: "Does the participant have any unscheduled GP/Urologist (outpatients) visits planned, not relating to the study (this can include visits resulting from UTI, UI, macroscopic haematuria, etc.?". If the answer to the question was "yes," the number of visits was recorded.', 'unitOfMeasure': 'visits', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As study progressed, participants dropped out the study.'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Change From Baseline in BPH Impact Index (BII) at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1574', 'groupId': 'OG000'}, {'value': '1593', 'groupId': 'OG001'}, {'value': '1582', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12', 'categories': [{'measurements': [{'value': '-1.9', 'spread': '0.06', 'groupId': 'OG000'}, {'value': '-1.5', 'spread': '0.06', 'groupId': 'OG001'}, {'value': '-1.6', 'spread': '0.06', 'groupId': 'OG002'}]}]}, {'title': 'Month 24', 'categories': [{'measurements': [{'value': '-2.1', 'spread': '0.07', 'groupId': 'OG000'}, {'value': '-1.7', 'spread': '0.07', 'groupId': 'OG001'}, {'value': '-1.5', 'spread': '0.07', 'groupId': 'OG002'}]}]}, {'title': 'Month 36', 'categories': [{'measurements': [{'value': '-2.2', 'spread': '0.07', 'groupId': 'OG000'}, {'value': '-1.8', 'spread': '0.07', 'groupId': 'OG001'}, {'value': '-1.3', 'spread': '0.07', 'groupId': 'OG002'}]}]}, {'title': 'Month 48', 'categories': [{'measurements': [{'value': '-2.2', 'spread': '0.07', 'groupId': 'OG000'}, {'value': '-1.8', 'spread': '0.07', 'groupId': 'OG001'}, {'value': '-1.2', 'spread': '0.07', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': "The BII is a 4-item questionnaire, score range of 0 (best) to 12 (worst) for questions 1-3, and 0 (best) to 13 (worst) for question 4, that assesses the overall impact of BPH on a participant's general sense of well being and measures aspects of physical discomfort, worry, and bother, all of which can be affected by BPH and its symptoms. BII score = sum of questions 1-4. Change from baseline = Post-Baseline Value. Estimates are based on the adjusted (least squares) means from the general linear model: change from baseline BII = treatment + cluster + baseline BII.", 'unitOfMeasure': 'points on a scale', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Adjusted Mean Change From Baseline in BPH-Related Health Status (BHS) at Months 12, 24, 36, and 48', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1575', 'groupId': 'OG000'}, {'value': '1592', 'groupId': 'OG001'}, {'value': '1583', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Month 12', 'categories': [{'measurements': [{'value': '-1.2', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '-1.0', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '-1.0', 'spread': '0.03', 'groupId': 'OG002'}]}]}, {'title': 'Month 24', 'categories': [{'measurements': [{'value': '-1.4', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '-1.1', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '-1.1', 'spread': '0.03', 'groupId': 'OG002'}]}]}, {'title': 'Month 36', 'categories': [{'measurements': [{'value': '-1.5', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '-1.2', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '-1.1', 'spread': '0.03', 'groupId': 'OG002'}]}]}, {'title': 'Month 48', 'categories': [{'measurements': [{'value': '-1.5', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '-1.3', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '-1.1', 'spread': '0.03', 'groupId': 'OG002'}]}]}], 'paramType': 'LEAST_SQUARES_MEAN', 'timeFrame': 'Baseline and Months 12, 24, 36, 48', 'description': 'The effect of study treatment on BHS was assessed by using three self-administered questionnaires: the International Prostate Symptom Score (IPSS), the BPH Impact Index (BII), and Patient Perception of Study Medication (PPSM). The BHS score was collected on the IPPS questionnaire and ranged from 0 (best) to 6 (worst). Percent change from baseline = \\[(post-baseline - baseline)/baseline value\\] x 100. Estimates were based on the adjusted (least squares) means from the general linear model: change from baseline BPH-related health status = treatment + cluster + baseline BPH-Related health status.', 'unitOfMeasure': 'points on a scale', 'dispersionType': 'Standard Error', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 1 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1685', 'groupId': 'OG000'}, {'value': '1600', 'groupId': 'OG001'}, {'value': '1586', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Improvement, n=1585, 1600, 1586', 'categories': [{'measurements': [{'value': '696', 'groupId': 'OG000'}, {'value': '656', 'groupId': 'OG001'}, {'value': '706', 'groupId': 'OG002'}]}]}, {'title': 'BL, No Change/Any Worsening, n=1585, 1600, 1586', 'categories': [{'measurements': [{'value': '889', 'groupId': 'OG000'}, {'value': '944', 'groupId': 'OG001'}, {'value': '880', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1281', 'groupId': 'OG000'}, {'value': '1171', 'groupId': 'OG001'}, {'value': '1218', 'groupId': 'OG002'}]}]}, {'title': 'M12, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '295', 'groupId': 'OG000'}, {'value': '422', 'groupId': 'OG001'}, {'value': '363', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1273', 'groupId': 'OG000'}, {'value': '1200', 'groupId': 'OG001'}, {'value': '1195', 'groupId': 'OG002'}]}]}, {'title': 'M24, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '303', 'groupId': 'OG000'}, {'value': '393', 'groupId': 'OG001'}, {'value': '386', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1268', 'groupId': 'OG000'}, {'value': '1203', 'groupId': 'OG001'}, {'value': '1152', 'groupId': 'OG002'}]}]}, {'title': 'M36, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '308', 'groupId': 'OG000'}, {'value': '390', 'groupId': 'OG001'}, {'value': '429', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1278', 'groupId': 'OG000'}, {'value': '1212', 'groupId': 'OG001'}, {'value': '1138', 'groupId': 'OG002'}]}]}, {'title': 'M48, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '298', 'groupId': 'OG000'}, {'value': '381', 'groupId': 'OG001'}, {'value': '443', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has control of your urinary problems changed?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 2 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1587', 'groupId': 'OG000'}, {'value': '1600', 'groupId': 'OG001'}, {'value': '1583', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=1587, 1600, 1583', 'categories': [{'measurements': [{'value': '707', 'groupId': 'OG000'}, {'value': '652', 'groupId': 'OG001'}, {'value': '686', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral/Any Dissatisfact., n=1587, 1600, 1583', 'categories': [{'measurements': [{'value': '880', 'groupId': 'OG000'}, {'value': '948', 'groupId': 'OG001'}, {'value': '897', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1224', 'groupId': 'OG000'}, {'value': '1127', 'groupId': 'OG001'}, {'value': '1178', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '352', 'groupId': 'OG000'}, {'value': '466', 'groupId': 'OG001'}, {'value': '403', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1261', 'groupId': 'OG000'}, {'value': '1166', 'groupId': 'OG001'}, {'value': '1150', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '315', 'groupId': 'OG000'}, {'value': '427', 'groupId': 'OG001'}, {'value': '431', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1260', 'groupId': 'OG000'}, {'value': '1167', 'groupId': 'OG001'}, {'value': '1120', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '316', 'groupId': 'OG000'}, {'value': '426', 'groupId': 'OG001'}, {'value': '461', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1267', 'groupId': 'OG000'}, {'value': '1172', 'groupId': 'OG001'}, {'value': '1088', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '309', 'groupId': 'OG000'}, {'value': '421', 'groupId': 'OG001'}, {'value': '493', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect of the study medication on control of your urinary problems?" Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 3 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1585', 'groupId': 'OG000'}, {'value': '1601', 'groupId': 'OG001'}, {'value': '1585', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Improvement, n=1585, 1601, 1585', 'categories': [{'measurements': [{'value': '629', 'groupId': 'OG000'}, {'value': '602', 'groupId': 'OG001'}, {'value': '615', 'groupId': 'OG002'}]}]}, {'title': 'BL, No Change/Any Worsening, n=1585, 1601, 1585', 'categories': [{'measurements': [{'value': '956', 'groupId': 'OG000'}, {'value': '999', 'groupId': 'OG001'}, {'value': '970', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Improvement, n=1576, 1593, 158', 'categories': [{'measurements': [{'value': '1181', 'groupId': 'OG000'}, {'value': '1044', 'groupId': 'OG001'}, {'value': '1105', 'groupId': 'OG002'}]}]}, {'title': 'M12, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '395', 'groupId': 'OG000'}, {'value': '549', 'groupId': 'OG001'}, {'value': '476', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1215', 'groupId': 'OG000'}, {'value': '1070', 'groupId': 'OG001'}, {'value': '1057', 'groupId': 'OG002'}]}]}, {'title': 'M24, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '361', 'groupId': 'OG000'}, {'value': '523', 'groupId': 'OG001'}, {'value': '524', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1206', 'groupId': 'OG000'}, {'value': '1071', 'groupId': 'OG001'}, {'value': '1023', 'groupId': 'OG002'}]}]}, {'title': 'M36, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '370', 'groupId': 'OG000'}, {'value': '522', 'groupId': 'OG001'}, {'value': '558', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Improvement, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1202', 'groupId': 'OG000'}, {'value': '1086', 'groupId': 'OG001'}, {'value': '1008', 'groupId': 'OG002'}]}]}, {'title': 'M48, No Change/Any Worsening, n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '374', 'groupId': 'OG000'}, {'value': '507', 'groupId': 'OG001'}, {'value': '573', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has the strength of your urinary stream changed?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 4 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1583', 'groupId': 'OG000'}, {'value': '1601', 'groupId': 'OG001'}, {'value': '1582', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=1583,1601,1582', 'categories': [{'measurements': [{'value': '632', 'groupId': 'OG000'}, {'value': '586', 'groupId': 'OG001'}, {'value': '613', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral/Any Dissatisfact., n=1583,1601,1582', 'categories': [{'measurements': [{'value': '951', 'groupId': 'OG000'}, {'value': '1015', 'groupId': 'OG001'}, {'value': '969', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1154', 'groupId': 'OG000'}, {'value': '1037', 'groupId': 'OG001'}, {'value': '1097', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '422', 'groupId': 'OG000'}, {'value': '556', 'groupId': 'OG001'}, {'value': '484', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1203', 'groupId': 'OG000'}, {'value': '1072', 'groupId': 'OG001'}, {'value': '1051', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '373', 'groupId': 'OG000'}, {'value': '521', 'groupId': 'OG001'}, {'value': '530', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1201', 'groupId': 'OG000'}, {'value': '1075', 'groupId': 'OG001'}, {'value': '1039', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '375', 'groupId': 'OG000'}, {'value': '518', 'groupId': 'OG001'}, {'value': '542', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '1208', 'groupId': 'OG000'}, {'value': '1089', 'groupId': 'OG001'}, {'value': '1022', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1576, 1593, 1581', 'categories': [{'measurements': [{'value': '368', 'groupId': 'OG000'}, {'value': '504', 'groupId': 'OG001'}, {'value': '559', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect of the study medication on the strength of your urinary stream?". Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 5 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '869', 'groupId': 'OG000'}, {'value': '901', 'groupId': 'OG001'}, {'value': '849', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Improvement, n=869, 901, 849', 'categories': [{'measurements': [{'value': '337', 'groupId': 'OG000'}, {'value': '331', 'groupId': 'OG001'}, {'value': '332', 'groupId': 'OG002'}]}]}, {'title': 'BL, No Change/Any Worsening, n=869, 901, 849', 'categories': [{'measurements': [{'value': '532', 'groupId': 'OG000'}, {'value': '570', 'groupId': 'OG001'}, {'value': '517', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Improvement, n=769, 817, 771', 'categories': [{'measurements': [{'value': '556', 'groupId': 'OG000'}, {'value': '526', 'groupId': 'OG001'}, {'value': '527', 'groupId': 'OG002'}]}]}, {'title': 'M12, No Change/Any Worsening, n=769, 817, 771', 'categories': [{'measurements': [{'value': '213', 'groupId': 'OG000'}, {'value': '291', 'groupId': 'OG001'}, {'value': '244', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Improvement, n=720, 780, 771', 'categories': [{'measurements': [{'value': '537', 'groupId': 'OG000'}, {'value': '526', 'groupId': 'OG001'}, {'value': '535', 'groupId': 'OG002'}]}]}, {'title': 'M24, No Change/Any Worsening, n=720, 780, 771', 'categories': [{'measurements': [{'value': '183', 'groupId': 'OG000'}, {'value': '254', 'groupId': 'OG001'}, {'value': '236', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Improvement, n=714, 753, 748', 'categories': [{'measurements': [{'value': '540', 'groupId': 'OG000'}, {'value': '514', 'groupId': 'OG001'}, {'value': '496', 'groupId': 'OG002'}]}]}, {'title': 'M36, No Change/Any Worsening, n=714, 753, 748', 'categories': [{'measurements': [{'value': '174', 'groupId': 'OG000'}, {'value': '239', 'groupId': 'OG001'}, {'value': '252', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Improvement, n=709, 756, 751', 'categories': [{'measurements': [{'value': '531', 'groupId': 'OG000'}, {'value': '510', 'groupId': 'OG001'}, {'value': '489', 'groupId': 'OG002'}]}]}, {'title': 'M48, No Change/Any Worsening, n=709, 756, 751', 'categories': [{'measurements': [{'value': '178', 'groupId': 'OG000'}, {'value': '246', 'groupId': 'OG001'}, {'value': '262', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has your pain prior to urinating changed?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 6 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1135', 'groupId': 'OG000'}, {'value': '1223', 'groupId': 'OG001'}, {'value': '1161', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=908, 932, 889', 'categories': [{'measurements': [{'value': '375', 'groupId': 'OG000'}, {'value': '351', 'groupId': 'OG001'}, {'value': '351', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral/Any Dissatisfact., n=908, 932, 889', 'categories': [{'measurements': [{'value': '533', 'groupId': 'OG000'}, {'value': '581', 'groupId': 'OG001'}, {'value': '538', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1022, 1088, 1019', 'categories': [{'measurements': [{'value': '712', 'groupId': 'OG000'}, {'value': '672', 'groupId': 'OG001'}, {'value': '681', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1022, 1088, 1019', 'categories': [{'measurements': [{'value': '310', 'groupId': 'OG000'}, {'value': '416', 'groupId': 'OG001'}, {'value': '338', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1077, 1151, 1085', 'categories': [{'measurements': [{'value': '764', 'groupId': 'OG000'}, {'value': '740', 'groupId': 'OG001'}, {'value': '708', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1077, 1151, 1085', 'categories': [{'measurements': [{'value': '313', 'groupId': 'OG000'}, {'value': '411', 'groupId': 'OG001'}, {'value': '377', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1115, 1200, 1135', 'categories': [{'measurements': [{'value': '799', 'groupId': 'OG000'}, {'value': '785', 'groupId': 'OG001'}, {'value': '736', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1115, 1200, 1135', 'categories': [{'measurements': [{'value': '316', 'groupId': 'OG000'}, {'value': '415', 'groupId': 'OG001'}, {'value': '399', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satisfact., n=1135, 1223, 1161', 'categories': [{'measurements': [{'value': '810', 'groupId': 'OG000'}, {'value': '792', 'groupId': 'OG001'}, {'value': '739', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1135, 1223, 1161', 'categories': [{'measurements': [{'value': '325', 'groupId': 'OG000'}, {'value': '431', 'groupId': 'OG001'}, {'value': '422', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your pain prior to urinating?". Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 7 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '852', 'groupId': 'OG000'}, {'value': '889', 'groupId': 'OG001'}, {'value': '822', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Improvement, n=852, 889, 822', 'categories': [{'measurements': [{'value': '321', 'groupId': 'OG000'}, {'value': '314', 'groupId': 'OG001'}, {'value': '319', 'groupId': 'OG002'}]}]}, {'title': 'BL, No Change/Any Worsening, n=852, 889, 822', 'categories': [{'measurements': [{'value': '531', 'groupId': 'OG000'}, {'value': '575', 'groupId': 'OG001'}, {'value': '503', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Improvement, n=760, 781, 755', 'categories': [{'measurements': [{'value': '550', 'groupId': 'OG000'}, {'value': '500', 'groupId': 'OG001'}, {'value': '529', 'groupId': 'OG002'}]}]}, {'title': 'M12, No Change/Any Worsening, n=760, 781, 755', 'categories': [{'measurements': [{'value': '210', 'groupId': 'OG000'}, {'value': '281', 'groupId': 'OG001'}, {'value': '226', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Improvement, n=706, 760, 747', 'categories': [{'measurements': [{'value': '532', 'groupId': 'OG000'}, {'value': '508', 'groupId': 'OG001'}, {'value': '519', 'groupId': 'OG002'}]}]}, {'title': 'M24, No Change/Any Worsening, n=706, 760, 747', 'categories': [{'measurements': [{'value': '174', 'groupId': 'OG000'}, {'value': '252', 'groupId': 'OG001'}, {'value': '228', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Improvement, n=704, 741, 733', 'categories': [{'measurements': [{'value': '529', 'groupId': 'OG000'}, {'value': '504', 'groupId': 'OG001'}, {'value': '491', 'groupId': 'OG002'}]}]}, {'title': 'M36, No Change/Any Worsening, n=704, 741, 733', 'categories': [{'measurements': [{'value': '175', 'groupId': 'OG000'}, {'value': '237', 'groupId': 'OG001'}, {'value': '242', 'groupId': 'OG002'}]}]}, {'title': 'M48, No Change/Any Worsening, n=702, 739, 740', 'categories': [{'measurements': [{'value': '175', 'groupId': 'OG000'}, {'value': '252', 'groupId': 'OG001'}, {'value': '257', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Improvement, n=702, 739, 740', 'categories': [{'measurements': [{'value': '527', 'groupId': 'OG000'}, {'value': '487', 'groupId': 'OG001'}, {'value': '483', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has your pain during urination changed?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 8 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1146', 'groupId': 'OG000'}, {'value': '1224', 'groupId': 'OG001'}, {'value': '1160', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=890, 925, 851', 'categories': [{'measurements': [{'value': '354', 'groupId': 'OG000'}, {'value': '348', 'groupId': 'OG001'}, {'value': '333', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral/Any Dissatisfact., n=890, 925, 851', 'categories': [{'measurements': [{'value': '536', 'groupId': 'OG000'}, {'value': '577', 'groupId': 'OG001'}, {'value': '518', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1022, 1088, 1011', 'categories': [{'measurements': [{'value': '712', 'groupId': 'OG000'}, {'value': '655', 'groupId': 'OG001'}, {'value': '678', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1022, 1088, 1011', 'categories': [{'measurements': [{'value': '310', 'groupId': 'OG000'}, {'value': '433', 'groupId': 'OG001'}, {'value': '333', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1077, 1155, 1079', 'categories': [{'measurements': [{'value': '763', 'groupId': 'OG000'}, {'value': '730', 'groupId': 'OG001'}, {'value': '708', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1077, 1155, 1079', 'categories': [{'measurements': [{'value': '314', 'groupId': 'OG000'}, {'value': '425', 'groupId': 'OG001'}, {'value': '371', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1121, 1206, 1131', 'categories': [{'measurements': [{'value': '807', 'groupId': 'OG000'}, {'value': '784', 'groupId': 'OG001'}, {'value': '724', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1121, 1206, 1131', 'categories': [{'measurements': [{'value': '314', 'groupId': 'OG000'}, {'value': '422', 'groupId': 'OG001'}, {'value': '407', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satsifact., n=1146,1224,1160', 'categories': [{'measurements': [{'value': '827', 'groupId': 'OG000'}, {'value': '785', 'groupId': 'OG001'}, {'value': '729', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1146, 1224, 1160', 'categories': [{'measurements': [{'value': '319', 'groupId': 'OG000'}, {'value': '439', 'groupId': 'OG001'}, {'value': '431', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your pain during urination?". Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 9 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1575', 'groupId': 'OG000'}, {'value': '1593', 'groupId': 'OG001'}, {'value': '1580', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Improvement, n=1574, 1599, 1575', 'categories': [{'measurements': [{'value': '509', 'groupId': 'OG000'}, {'value': '481', 'groupId': 'OG001'}, {'value': '494', 'groupId': 'OG002'}]}]}, {'title': 'BL, No Change/Any Worsening, n=1574, 1599, 1575', 'categories': [{'measurements': [{'value': '1065', 'groupId': 'OG000'}, {'value': '1118', 'groupId': 'OG001'}, {'value': '1081', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Improvement, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1124', 'groupId': 'OG000'}, {'value': '1027', 'groupId': 'OG001'}, {'value': '1084', 'groupId': 'OG002'}]}]}, {'title': 'M12, No Change/Any Worsening, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '451', 'groupId': 'OG000'}, {'value': '566', 'groupId': 'OG001'}, {'value': '496', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Improvement, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1146', 'groupId': 'OG000'}, {'value': '1053', 'groupId': 'OG001'}, {'value': '1049', 'groupId': 'OG002'}]}]}, {'title': 'M24, No Change/Any Worsening, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '429', 'groupId': 'OG000'}, {'value': '540', 'groupId': 'OG001'}, {'value': '531', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Improvement, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1575', 'groupId': 'OG000'}, {'value': '1593', 'groupId': 'OG001'}, {'value': '1580', 'groupId': 'OG002'}]}]}, {'title': 'M36, No Change/Any Worsening, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '412', 'groupId': 'OG000'}, {'value': '529', 'groupId': 'OG001'}, {'value': '553', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Improvement, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1148', 'groupId': 'OG000'}, {'value': '1063', 'groupId': 'OG001'}, {'value': '1008', 'groupId': 'OG002'}]}]}, {'title': 'M48, No Change/Any Worsening, n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '427', 'groupId': 'OG000'}, {'value': '530', 'groupId': 'OG001'}, {'value': '572', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has the way your urinary problems interfere with your ability to go about your usual activities changed?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 10 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1575', 'groupId': 'OG000'}, {'value': '1593', 'groupId': 'OG001'}, {'value': '1580', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=1574, 1600, 1576', 'categories': [{'measurements': [{'value': '611', 'groupId': 'OG000'}, {'value': '565', 'groupId': 'OG001'}, {'value': '584', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral /Any Dissatisfact., n=1574, 1600, 1576', 'categories': [{'measurements': [{'value': '963', 'groupId': 'OG000'}, {'value': '1035', 'groupId': 'OG001'}, {'value': '992', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1176', 'groupId': 'OG000'}, {'value': '1073', 'groupId': 'OG001'}, {'value': '1114', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '399', 'groupId': 'OG000'}, {'value': '520', 'groupId': 'OG001'}, {'value': '466', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1205', 'groupId': 'OG000'}, {'value': '1116', 'groupId': 'OG001'}, {'value': '1088', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '370', 'groupId': 'OG000'}, {'value': '477', 'groupId': 'OG001'}, {'value': '492', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1210', 'groupId': 'OG000'}, {'value': '1098', 'groupId': 'OG001'}, {'value': '1074', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '365', 'groupId': 'OG000'}, {'value': '495', 'groupId': 'OG001'}, {'value': '506', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '1213', 'groupId': 'OG000'}, {'value': '1123', 'groupId': 'OG001'}, {'value': '1043', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1575, 1593, 1580', 'categories': [{'measurements': [{'value': '362', 'groupId': 'OG000'}, {'value': '470', 'groupId': 'OG001'}, {'value': '537', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your ability to go about your usual activities without interference from your urinary problems?". Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 11 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1574', 'groupId': 'OG000'}, {'value': '1592', 'groupId': 'OG001'}, {'value': '1581', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline (BL), Any Satisfact., n=1573, 1598, 1574', 'categories': [{'measurements': [{'value': '717', 'groupId': 'OG000'}, {'value': '683', 'groupId': 'OG001'}, {'value': '699', 'groupId': 'OG002'}]}]}, {'title': 'BL, Neutral/Any Dissatisfact., n=1573, 1598, 1574', 'categories': [{'measurements': [{'value': '856', 'groupId': 'OG000'}, {'value': '915', 'groupId': 'OG001'}, {'value': '875', 'groupId': 'OG002'}]}]}, {'title': 'Month (M) 12, Any Satisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '150', 'groupId': 'OG000'}, {'value': '1159', 'groupId': 'OG001'}, {'value': '1202', 'groupId': 'OG002'}]}]}, {'title': 'M12, Neutral/Any Dissatisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '324', 'groupId': 'OG000'}, {'value': '433', 'groupId': 'OG001'}, {'value': '379', 'groupId': 'OG002'}]}]}, {'title': 'M24, Any Satisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1279', 'groupId': 'OG000'}, {'value': '1188', 'groupId': 'OG001'}, {'value': '1163', 'groupId': 'OG002'}]}]}, {'title': 'M24, Neutral/Any Dissatisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '295', 'groupId': 'OG000'}, {'value': '404', 'groupId': 'OG001'}, {'value': '418', 'groupId': 'OG002'}]}]}, {'title': 'M36, Any Satisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1270', 'groupId': 'OG000'}, {'value': '1188', 'groupId': 'OG001'}, {'value': '1119', 'groupId': 'OG002'}]}]}, {'title': 'M36, Neutral/Any Dissatisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '304', 'groupId': 'OG000'}, {'value': '404', 'groupId': 'OG001'}, {'value': '462', 'groupId': 'OG002'}]}]}, {'title': 'M48, Any Satifact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1262', 'groupId': 'OG000'}, {'value': '1182', 'groupId': 'OG001'}, {'value': '1097', 'groupId': 'OG002'}]}]}, {'title': 'M48, Neutral/Any Dissatisfact., n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '312', 'groupId': 'OG000'}, {'value': '410', 'groupId': 'OG001'}, {'value': '484', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Overall, how satisfied are you with the study medication and it\'s effect on your urinary problems?". Satisfact., satisfaction.', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}, {'type': 'SECONDARY', 'title': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 12 (LOCF)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1574', 'groupId': 'OG000'}, {'value': '1592', 'groupId': 'OG001'}, {'value': '1581', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'OG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'OG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'classes': [{'title': 'Baseline, Yes, n=1560, 1579, 1562', 'categories': [{'measurements': [{'value': '587', 'groupId': 'OG000'}, {'value': '557', 'groupId': 'OG001'}, {'value': '582', 'groupId': 'OG002'}]}]}, {'title': 'Baseline, No/Not Sure, n=1560, 1579, 1562', 'categories': [{'measurements': [{'value': '973', 'groupId': 'OG000'}, {'value': '1022', 'groupId': 'OG001'}, {'value': '980', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, Yes, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '972', 'groupId': 'OG000'}, {'value': '920', 'groupId': 'OG001'}, {'value': '970', 'groupId': 'OG002'}]}]}, {'title': 'Month 12, No/Not Sure, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '602', 'groupId': 'OG000'}, {'value': '671', 'groupId': 'OG001'}, {'value': '611', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, Yes, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1027', 'groupId': 'OG000'}, {'value': '955', 'groupId': 'OG001'}, {'value': '952', 'groupId': 'OG002'}]}]}, {'title': 'Month 24, No/Not Sure, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '547', 'groupId': 'OG000'}, {'value': '636', 'groupId': 'OG001'}, {'value': '629', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, Yes, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1031', 'groupId': 'OG000'}, {'value': '956', 'groupId': 'OG001'}, {'value': '915', 'groupId': 'OG002'}]}]}, {'title': 'Month 36, No/Not Sure, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '543', 'groupId': 'OG000'}, {'value': '636', 'groupId': 'OG001'}, {'value': '666', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, Yes, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '1003', 'groupId': 'OG000'}, {'value': '918', 'groupId': 'OG001'}, {'value': '874', 'groupId': 'OG002'}]}]}, {'title': 'Month 48, No/Not Sure, n=1574, 1592, 1581', 'categories': [{'measurements': [{'value': '571', 'groupId': 'OG000'}, {'value': '674', 'groupId': 'OG001'}, {'value': '707', 'groupId': 'OG002'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Would you ask your doctor for the medication you received in this study?".', 'unitOfMeasure': 'participants', 'reportingStatus': 'POSTED', 'populationDescription': 'ITT Population. As the study progressed, participants dropped out of the study. Only participants responding to the question were analyzed.'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'FG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'FG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}], 'periods': [{'title': 'Four-Year Double-Blind Treatment Period', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1610'}, {'groupId': 'FG001', 'numSubjects': '1623'}, {'groupId': 'FG002', 'numSubjects': '1611'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1113'}, {'groupId': 'FG001', 'numSubjects': '1093'}, {'groupId': 'FG002', 'numSubjects': '989'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '497'}, {'groupId': 'FG001', 'numSubjects': '530'}, {'groupId': 'FG002', 'numSubjects': '622'}]}], 'dropWithdraws': [{'type': 'Adverse Event', 'reasons': [{'groupId': 'FG000', 'numSubjects': '211'}, {'groupId': 'FG001', 'numSubjects': '185'}, {'groupId': 'FG002', 'numSubjects': '210'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '114'}, {'groupId': 'FG001', 'numSubjects': '160'}, {'groupId': 'FG002', 'numSubjects': '148'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '53'}, {'groupId': 'FG001', 'numSubjects': '48'}, {'groupId': 'FG002', 'numSubjects': '58'}]}, {'type': 'Protocol Violation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '29'}, {'groupId': 'FG001', 'numSubjects': '29'}, {'groupId': 'FG002', 'numSubjects': '34'}]}, {'type': 'Lack of Efficacy', 'reasons': [{'groupId': 'FG000', 'numSubjects': '53'}, {'groupId': 'FG001', 'numSubjects': '71'}, {'groupId': 'FG002', 'numSubjects': '104'}]}, {'type': 'Participant Relocated', 'reasons': [{'groupId': 'FG000', 'numSubjects': '7'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '8'}]}, {'type': 'Site Closed/Sponsor Termination', 'reasons': [{'groupId': 'FG000', 'numSubjects': '7'}, {'groupId': 'FG001', 'numSubjects': '7'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'Non-compliant/Medication Interruption', 'reasons': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '4'}, {'groupId': 'FG002', 'numSubjects': '7'}]}, {'type': 'Prostate Surgery/TURP/Alt. Therapy', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '7'}, {'groupId': 'FG002', 'numSubjects': '19'}]}, {'type': 'Participant Decision/Withdrawn', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'Acute Urinary Retention (AUR)', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '6'}]}, {'type': 'Prohibited Medication', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '8'}]}, {'type': 'Investigator Departure', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Alcohol Dependent', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Screen Failure', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'No Improvement', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'BPH/BPH symptoms worse/urinary incont.', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '5'}]}, {'type': 'Financial Problems', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Loss of Libido', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Angina Pectoris', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Loss of Contact', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Neoplasm of Bladder/Prostate', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Cardiologist/Neurologist Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Renal Insufficiency', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Back Pain', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Scheduling Issues', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Any Appreciable Improvement', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Investigator Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '3'}]}, {'type': 'Enrollment Error', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '2'}]}, {'type': 'Urinary Tract Infection (UTI)', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Prostate Specific Antigen Rising', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}, {'title': '16-Week Safety Follow-up Period', 'milestones': [{'type': 'STARTED', 'achievements': [{'comment': "Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.", 'groupId': 'FG000', 'numSubjects': '1598'}, {'comment': "Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.", 'groupId': 'FG001', 'numSubjects': '1615'}, {'comment': "Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.", 'groupId': 'FG002', 'numSubjects': '1600'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1224'}, {'groupId': 'FG001', 'numSubjects': '1205'}, {'groupId': 'FG002', 'numSubjects': '1143'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '374'}, {'groupId': 'FG001', 'numSubjects': '410'}, {'groupId': 'FG002', 'numSubjects': '457'}]}], 'dropWithdraws': [{'type': 'Adverse Event', 'reasons': [{'groupId': 'FG000', 'numSubjects': '34'}, {'groupId': 'FG001', 'numSubjects': '39'}, {'groupId': 'FG002', 'numSubjects': '44'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '185'}, {'groupId': 'FG001', 'numSubjects': '212'}, {'groupId': 'FG002', 'numSubjects': '229'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '101'}, {'groupId': 'FG001', 'numSubjects': '97'}, {'groupId': 'FG002', 'numSubjects': '111'}]}, {'type': 'Protocol Violation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '18'}, {'groupId': 'FG001', 'numSubjects': '18'}, {'groupId': 'FG002', 'numSubjects': '17'}]}, {'type': 'Site Closed/Sponsor Termination', 'reasons': [{'groupId': 'FG000', 'numSubjects': '8'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'Non-compliant/Medication Interruption', 'reasons': [{'groupId': 'FG000', 'numSubjects': '8'}, {'groupId': 'FG001', 'numSubjects': '6'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'Loss of Contact', 'reasons': [{'groupId': 'FG000', 'numSubjects': '4'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '2'}]}, {'type': 'Disease Progression/Treatment Failure', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Participant relocated', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Participant Decision/Withdrawn', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '2'}]}, {'type': 'Prohibited Medication', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '5'}]}, {'type': 'Alcohol Dependent', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Prostate surgery/TURP/Alt. therapy', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '13'}]}, {'type': 'Loss of Libido', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Enrollment Error', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '2'}]}, {'type': 'Neoplasm of Bladder/Prostate Cancer', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '3'}, {'groupId': 'FG002', 'numSubjects': '6'}]}, {'type': 'Death', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}]}, {'type': 'Gyneomastia', 'reasons': [{'groupId': 'FG000', 'numSubjects': '1'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Acute Urinary Retention (AUR)', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '5'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'BPH/BPH symptoms worse/urinary incont.', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '3'}]}, {'type': 'Angina Pectoris', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Back Pain', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Scheduling Issues', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '4'}]}, {'type': 'Investigator/Sponsor Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '2'}, {'groupId': 'FG002', 'numSubjects': '3'}]}, {'type': 'Depression', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Diabetes Uncontrolled', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Jailed', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}, {'type': 'Other', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '1'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}], 'preAssignmentDetails': 'In a 4-week, single-blind placebo run-in period, all participants (par.) took two capsules consisting of one dutasteride-matched placebo capsule and one tamsulosin-matched placebo capsule once daily for 4 weeks. A safety follow-up was performed for all participants 16 weeks after the last dose of study drug.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '1610', 'groupId': 'BG000'}, {'value': '1623', 'groupId': 'BG001'}, {'value': '1611', 'groupId': 'BG002'}, {'value': '4844', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Dutasteride 0.5 mg Plus Tamsulosin 0.4 mg', 'description': 'Dutasteride 0.5 milligrams (mg) plus tamsulosin 0.4 mg once daily for 208 weeks'}, {'id': 'BG001', 'title': 'Dutasteride 0.5 mg', 'description': 'Dutasteride 0.5 mg plus tamsulosin placebo once daily for 208 weeks'}, {'id': 'BG002', 'title': 'Tamsulosin 0.4 mg', 'description': 'Tamsulosin 0.4 mg plus dutasteride placebo once daily for 208 weeks'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '66.0', 'spread': '7.05', 'groupId': 'BG000'}, {'value': '66.0', 'spread': '6.99', 'groupId': 'BG001'}, {'value': '66.2', 'spread': '7.00', 'groupId': 'BG002'}, {'value': '66.1', 'spread': '7.01', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Gender', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '1610', 'groupId': 'BG000'}, {'value': '1623', 'groupId': 'BG001'}, {'value': '1611', 'groupId': 'BG002'}, {'value': '4844', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'White', 'categories': [{'measurements': [{'value': '1421', 'groupId': 'BG000'}, {'value': '1433', 'groupId': 'BG001'}, {'value': '1405', 'groupId': 'BG002'}, {'value': '4259', 'groupId': 'BG003'}]}]}, {'title': 'Black', 'categories': [{'measurements': [{'value': '22', 'groupId': 'BG000'}, {'value': '17', 'groupId': 'BG001'}, {'value': '24', 'groupId': 'BG002'}, {'value': '63', 'groupId': 'BG003'}]}]}, {'title': 'Asian', 'categories': [{'measurements': [{'value': '107', 'groupId': 'BG000'}, {'value': '106', 'groupId': 'BG001'}, {'value': '112', 'groupId': 'BG002'}, {'value': '325', 'groupId': 'BG003'}]}]}, {'title': 'American Hispanic', 'categories': [{'measurements': [{'value': '44', 'groupId': 'BG000'}, {'value': '48', 'groupId': 'BG001'}, {'value': '55', 'groupId': 'BG002'}, {'value': '147', 'groupId': 'BG003'}]}]}, {'title': 'Unknown', 'categories': [{'measurements': [{'value': '16', 'groupId': 'BG000'}, {'value': '19', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '50', 'groupId': 'BG003'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 4844}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2003-11'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-01', 'completionDateStruct': {'date': '2009-04', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-01-16', 'studyFirstSubmitDate': '2004-08-24', 'resultsFirstSubmitDate': '2010-02-26', 'studyFirstSubmitQcDate': '2004-08-25', 'lastUpdatePostDateStruct': {'date': '2017-02-28', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2010-02-26', 'studyFirstPostDateStruct': {'date': '2004-08-26', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2010-03-16', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2009-04', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of Events of Acute Urinary Retention (AUR) or Benign Prostatic Hyperplasia (BPH)-Related Prostatic Surgery at the Indicated Time Periods.', 'timeFrame': 'Years 1, 2, 3, and 4', 'description': "A participant was considered to have AUR when he was unable to urinate and required bladder catheterization. BPH is also known as an enlarged prostate. When symptoms of BPH become bothersome, surgery may be required. When events of AUR and BPH-related surgery were participant-reported or identified, they were recorded in the participants' clinic record."}, {'measure': 'Number of Participants With AUR or BPH-related Surgery', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': "A participant was considered to have AUR when he was unable to urinate and required bladder catheterization. BPH is also known as an enlarged prostate. When symptoms of BPH become bothersome, surgery may be required. When events of AUR and BPH-related surgery were participant reported or identified, they were recorded in the participants' clinic record."}], 'secondaryOutcomes': [{'measure': 'Number of Events of First BPH Clinical Progression at Years 1, 2, 3 and 4', 'timeFrame': 'Years 1, 2, 3, and 4', 'description': "The time when the first symptom/event of BPH clinical progression has occurred (i.e. AUR, incontinence) was measured. Summaries are based on the first occuring event after treatment start. The time period is from treatment start to each participant's last treatment visit. The Year 4 events include all those that occur during the fourth year and beyond."}, {'measure': 'The Number of Participants With Each of the Five Components of BPH Clinical Progression', 'timeFrame': 'Baseline (Day 1) to Year 4', 'description': 'The five components measured were symptom deterioration, BPH-related AUR, BPH-related incontinence, recurrent BPH-related Urinary Tract Infection (UTI), and BPH-related renal insufficiency.'}, {'measure': 'Number of Events of Symptom Deterioration at the Indicated Time Periods', 'timeFrame': "Years 1, 2, 3, and 4 (from treatment start until each participant's last treatment-phase visit)", 'description': 'The number of participants (par.) with symptom deterioration of International Prostate Symptom Score (IPSS) ≥4 points on two consecutive visits post-baseline are presented. Data are based on the first occurrence of an event after treatment start. The year-4 events include all that occured during the 4th year and beyond. The IPSS is a 7-item questionnaire measuring the level of urinary symptoms reported as the total score. Each question has a 6-point response scale (0=none/not at all to 5=almost always), with a total score ranging from 0-35: mild (0-7), moderate (8-19), or severe (20-35).'}, {'measure': 'Number of Participants With an Event of Post-baseline BPH-related Macroscopic Hematuria', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': 'A participant was considered to have macroscopic hematuria when there was presence of blood in the urine. The event of macroscopic hematuria was either participant-reported or identified by the investigator during a clinic visit. Overall Crude Rate is the number of participants from the total number analyzed that experience experienced an incident of post-baseline BPH or Non-BPH related macroscopic hematuria. Participants may appear in both categories.'}, {'measure': 'Number of Participants With an Event of Post-baseline BPH-related Hematospermia', 'timeFrame': 'Baseline (Day 1) through Year 4', 'description': 'A participant was considered to have hematospermia when there was presence of blood in the semen. Hematospermia can occur from prostatitis (prostate infection), from cancer, or after a prostate biopsy. The event of hematospermia was either participant-reported or identified by the investigator during a clinic visit. Overall Crude Rate is the number of participants from the total number analyzed that experience experienced an incident of post-baseline BPH or Non-BPH related hematospermia. Participants may appear in both categories.'}, {'measure': 'Adjusted Mean Change From Baseline in International Prostate Symptom Score (IPSS) at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'The IPSS is a 7-item questionnaire that measures urinary symptoms. It measures the level of urinary symptoms (including incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia) reported as the total IPSS score. Each of the 7 questions has a 6-point response scale (0=none/not at all to 5=almost always) with a total score that can range from 0-35: mild (0-7), moderate (8-19), or severe (20-35). Estimates are based on adjusted (least squares) means from the general linear model: change from baseline IPSS = Treatment + Cluster + Baseline IPSS.'}, {'measure': 'Adjusted Mean Change From Baseline in Urinary Flow Rate (Qmax) at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Peak maximum urinary flow (Qmax) of urinary flow using a Medtronic (formerly Dantec) Uroflow Meter (Urodyn 1000 or Duet models) with a Thompson filter was measured. Estimates are based on adjusted (least squares) means from the general linear model: Change from baseline Qmax = treatment + cluster + baseline Qmax.'}, {'measure': 'Adjusted Mean Percent Change From Baseline in Prostate Volume at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Prostate volume measurements were conducted annually using Transurethral ultrasound (TRUS). The anteroposterior, cephalocaudal, and transverse diameters of the prostate obtained by TRUS calculate the total prostate volume centimeters (cc). Percent change from baseline = \\[(post-baseline - baseline)/baseline value\\] x 100. Estimates were based on the adjusted (least squares) means from the general linear model: log(post-baseline/baseline value) + treatment + cluster + log(baseline value) and are reported as percent change from baseline.'}, {'measure': 'Adjusted Mean Change From Baseline in Transition Zone (Portion of the Prostate That Surrounds the Proximal Urethra) Volume at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'Prostate volume (PV) measurements were conducted annually using Transurethral ultrasound (TRUS). The anteroposterior, cephalocaudal, and transverse diameters of the prostate obtained by TRUS calculate the total PV in centimeters (cc). Results are for the transition zone measurements of the prostate in a small subset of participants. Percent change from baseline (BL) = \\[(post-BL - BL)/BL value\\] x 100. Estimates are based on the adjusted (least squares) means for the general linear model: log(post-BL/BL value) = treatment + cluster + log(BL value) and are reported as percent change from BL.'}, {'measure': 'Number of Unscheduled Visits to GP/Urologist Regarding AUR Symptoms Since the Last Study Visit', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with an episode of AUR. Responses to the following question were recorded: "Has the participant needed to make any unscheduled visits to his general practitioner (GP)/Urologist regarding AUR symptoms since the last study visit?" If the answer to the question was "yes," the number of visits was recorded.'}, {'measure': 'Number of "Yes" Responses to the Question: "Would the Participant Have Paid a Visit to His GP/Urologist Regarding AUR Symptoms if the Study Visit Had Not Been Planned"?.', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with an episode of AUR. Responses to the following question were recorded: "Would the participant have paid a visit to his GP/Urologist regarding AUR symptoms if this study visit had not been planned?". If the answer to the question was "yes," the number of Yes responses was recorded.'}, {'measure': 'Number of Visits to GP/Urologist Regarding BPH-related Surgery Since the Last Study Visit', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with BPH-related surgery. Responses to the following question were recorded: "Has the participant needed to visit his general practitioner (GP)/Urologist regarding BPH-related surgery since the last study visit?". If the answer to the question was "yes," the number of visits was recorded.'}, {'measure': 'Number of "Yes" Responses to the Question: "Would the Participant Have Paid a Visit to His GP/Urologist Regarding BPH-related Surgery Since the Last Study Visit?"', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with BPH-related surgery. Responses to the following question were recorded: "Would the participant have paid a visit to his general practitioner (GP)/Urologist regarding BPH-related surgery since the last study visit?". If the answer to the question was "yes," the number of Yes responses was recorded.'}, {'measure': 'Number of Unplanned Visits to GP/Urologist That Would Have Taken Place if a Scheduled Study Visit Had Not Been Planned (Including Visits Resulting From UTI, UI, Macroscopic Haematuria, Etc.)', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with unplanned visits to GP/Urologist. Responses to the following question were recorded: "Has the participant had any unplanned GP/Urologist (outpatient) visits that would have taken place if a scheduled study visit had not been planned (this can include visits resulting from UTI, UI macroscopic haematuria, etc?". If the answer to the question was "yes," the number of visits was recorded.'}, {'measure': 'Number of Unscheduled Visits to GP/Urologist (Outpatient) Planned, Not Relating to the Study (Including Visits Resulting From UTI, UI, Macroscopic Haematuria, Etc.)', 'timeFrame': 'Every 3 months from Month 3 to Month 48', 'description': 'At each scheduled 13-week clinic visit post-randomization, the investigator was to record details of any health care utilization associated with unplanned visits to GP/Urologist. Responses to the following question were recorded: "Does the participant have any unscheduled GP/Urologist (outpatients) visits planned, not relating to the study (this can include visits resulting from UTI, UI, macroscopic haematuria, etc.?". If the answer to the question was "yes," the number of visits was recorded.'}, {'measure': 'Adjusted Mean Change From Baseline in BPH Impact Index (BII) at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': "The BII is a 4-item questionnaire, score range of 0 (best) to 12 (worst) for questions 1-3, and 0 (best) to 13 (worst) for question 4, that assesses the overall impact of BPH on a participant's general sense of well being and measures aspects of physical discomfort, worry, and bother, all of which can be affected by BPH and its symptoms. BII score = sum of questions 1-4. Change from baseline = Post-Baseline Value. Estimates are based on the adjusted (least squares) means from the general linear model: change from baseline BII = treatment + cluster + baseline BII."}, {'measure': 'Adjusted Mean Change From Baseline in BPH-Related Health Status (BHS) at Months 12, 24, 36, and 48', 'timeFrame': 'Baseline and Months 12, 24, 36, 48', 'description': 'The effect of study treatment on BHS was assessed by using three self-administered questionnaires: the International Prostate Symptom Score (IPSS), the BPH Impact Index (BII), and Patient Perception of Study Medication (PPSM). The BHS score was collected on the IPPS questionnaire and ranged from 0 (best) to 6 (worst). Percent change from baseline = \\[(post-baseline - baseline)/baseline value\\] x 100. Estimates were based on the adjusted (least squares) means from the general linear model: change from baseline BPH-related health status = treatment + cluster + baseline BPH-Related health status.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 1 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has control of your urinary problems changed?".'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 2 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect of the study medication on control of your urinary problems?" Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 3 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has the strength of your urinary stream changed?".'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 4 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect of the study medication on the strength of your urinary stream?". Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 5 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has your pain prior to urinating changed?".'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 6 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your pain prior to urinating?". Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 7 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has your pain during urination changed?".'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 8 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your pain during urination?". Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 9 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Since you began taking the study medication, how has the way your urinary problems interfere with your ability to go about your usual activities changed?".'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 10 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "How satisfied are you with the effect the study medication has on your ability to go about your usual activities without interference from your urinary problems?". Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 11 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Overall, how satisfied are you with the study medication and it\'s effect on your urinary problems?". Satisfact., satisfaction.'}, {'measure': 'Patient Perception of Study Medication (PPSM): Number of Participants With the Indicated Responses to Question 12 (LOCF)', 'timeFrame': 'Baseline and Months 12, 24, 36, and 48', 'description': 'This 12-item questionnaire (PPSM) was developed by GlaxoSmithKline for use in this study and was designed to quantify the participant\'s perceptions and satisfaction with the effect of study treatment on control of their urinary symptoms at baseline and Months 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45, and 48. Participants were asked to respond to the question of "Would you ask your doctor for the medication you received in this study?".'}]}, 'conditionsModule': {'keywords': ['Combination Therapy', 'dutasteride', 'BPH'], 'conditions': ['Prostatic Hyperplasia']}, 'referencesModule': {'availIpds': [{'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Annotated Case Report Form', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Informed Consent Form', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Statistical Analysis Plan', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Clinical Study Report', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Study Protocol', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Individual Participant Data Set', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}, {'id': 'ARI40005', 'url': 'https://www.clinicalstudydatarequest.com', 'type': 'Dataset Specification', 'comment': 'For additional information about this study please refer to the GSK Clinical Study Register'}], 'references': [{'pmid': '21269736', 'type': 'BACKGROUND', 'citation': 'Antonanzas F, Brenes F, Molero JM, Fernandez-Pro A, Huerta A, Palencia R, Cozar JM. [Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain]. Actas Urol Esp. 2011 Feb;35(2):65-71. doi: 10.1016/j.acuro.2010.11.008. Epub 2011 Jan 26. Spanish.'}, {'pmid': '19239460', 'type': 'BACKGROUND', 'citation': 'Barkin J, Roehrborn CG, Siami P, Haillot O, Morrill B, Black L, Montorsi F; CombAT Study Group. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial. BJU Int. 2009 Apr;103(7):919-26. doi: 10.1111/j.1464-410X.2009.08196.x. Epub 2009 Feb 23.'}, {'pmid': '21933326', 'type': 'BACKGROUND', 'citation': 'Bjerklund Johansen TE, Baker TM, Black LK. Cost-effectiveness of combination therapy for treatment of benign prostatic hyperplasia: a model based on the findings of the Combination of Avodart and Tamsulosin trial. BJU Int. 2012 Mar;109(5):731-8. doi: 10.1111/j.1464-410X.2011.10511.x. Epub 2011 Sep 20.'}, {'pmid': '19545384', 'type': 'BACKGROUND', 'citation': 'Black L, Grove A, Morrill B. The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms. Health Qual Life Outcomes. 2009 Jun 19;7:55. doi: 10.1186/1477-7525-7-55.'}, {'pmid': '18813219', 'type': 'BACKGROUND', 'citation': 'Chung BH, Roehrborn CG, Siami P, Major-Walker K, Morrill BB, Wilson TH, Montorsi F. Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH. Prostate Cancer Prostatic Dis. 2009;12(2):152-9. doi: 10.1038/pcan.2008.49. Epub 2008 Sep 23.'}, {'pmid': '19825505', 'type': 'BACKGROUND', 'citation': 'Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F; CombAT Study Group. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010 Jan;57(1):123-31. doi: 10.1016/j.eururo.2009.09.035. Epub 2009 Sep 19.'}, {'pmid': '21093145', 'type': 'BACKGROUND', 'citation': 'Roehrborn CG, Andriole GL, Wilson TH, Castro R, Rittmaster RS. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial. Eur Urol. 2011 Feb;59(2):244-9. doi: 10.1016/j.eururo.2010.10.040. Epub 2010 Nov 4.'}, {'pmid': '21332630', 'type': 'BACKGROUND', 'citation': 'Roehrborn CG, Barkin J, Siami P, Tubaro A, Wilson TH, Morrill BB, Gagnier RP. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int. 2011 Mar;107(6):946-54. doi: 10.1111/j.1464-410X.2011.10124.x. Epub 2011 Feb 18.'}, {'pmid': '22425127', 'type': 'BACKGROUND', 'citation': 'Roehrborn CG, Wilson TH, Black LK. Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. J Urol. 2012 May;187(5):1732-8. doi: 10.1016/j.juro.2011.12.083. Epub 2012 Mar 15.'}, {'pmid': '19901936', 'type': 'BACKGROUND', 'citation': 'Becher E, Roehrborn CG, Siami P, Gagnier RP, Wilson TH, Montorsi F. The effects of dutasteride, tamsulosin, and the combination on storage and voiding in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the Combination of Avodart and Tamsulosin study. Prostate Cancer Prostatic Dis. 2009;12(4):369-74. doi: 10.1038/pcan.2009.37. Epub 2009 Sep 1.'}, {'pmid': '21348912', 'type': 'BACKGROUND', 'citation': 'Montorsi F, Roehrborn C, Garcia-Penit J, Borre M, Roeleveld TA, Alimi JC, Gagnier P, Wilson TH. The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study. BJU Int. 2011 May;107(9):1426-31. doi: 10.1111/j.1464-410X.2011.10129.x. Epub 2011 Feb 23.'}, {'pmid': '20487046', 'type': 'BACKGROUND', 'citation': 'Montorsi F, Henkel T, Geboers A, Mirone V, Arrosagaray P, Morrill B, Black L. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 4-year data from the CombAT study. Int J Clin Pract. 2010 Jul;64(8):1042-51. doi: 10.1111/j.1742-1241.2010.02428.x. Epub 2010 May 7.'}, {'pmid': '21502969', 'type': 'BACKGROUND', 'citation': 'Haillot O, Fraga A, Maciukiewicz P, Pushkar D, Tammela T, Hofner K, Chantada V, Gagnier P, Morrill B. The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study. Prostate Cancer Prostatic Dis. 2011 Dec;14(4):302-6. doi: 10.1038/pcan.2011.13. Epub 2011 Apr 19.'}, {'pmid': '18082216', 'type': 'BACKGROUND', 'citation': 'Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Morrill B, Montorsi F; CombAT Study Group. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol. 2008 Feb;179(2):616-21; discussion 621. doi: 10.1016/j.juro.2007.09.084. Epub 2007 Dec 21.'}], 'seeAlsoLinks': [{'url': 'https://www.clinicalstudydatarequest.com', 'label': 'Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.'}]}, 'descriptionModule': {'briefSummary': 'This study will investigate the efficacy and safety of treatment with dutasteride and tamsulosin, administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH). Study visits are every 3 months for up to 4 years (18 clinic visits). Transrectal ultrasound (TRUS) is done annually.', 'detailedDescription': 'A randomised, double-blind, parallel group study to investigate the efficacy and safety of treatment with Dutasteride (0.5 mg) and Tamsulosin (0.4 mg), administered once daily for 4 years, alone and in combination, on the improvement of symptoms and clinical outcome in men with moderate to severe symptomatic benign prostatic hyperplasia.'}, 'eligibilityModule': {'sex': 'MALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '50 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion criteria:\n\n* A subject will be considered eligible for inclusion in this study only if all of the following criteria apply:\n* males, aged ≥50 years\n* clinical diagnosis of BPH by medical history and physical examination, including a digital rectal examination (DRE)\n* International Prostate Symptom Score (IPSS) ≥12 points at Screening\n* prostate volume ≥30 cc by transrectal ultrasonography; (TRUS)\n* total serum Prostate Specific Antigen (PSA) ≥1.5ng/mL at Screening\n* maximum flow rate (Qmax) \\>5 mL/sec and ≤15 mL/sec and minimum voided volume of ≥125 mL at Screening (based on two voids)\n* willing and able to give written informed consent and comply with study procedures\n* fluent and literate in local language with the ability to read, comprehend and record information on the IPSS, BII and Patient Perception of Study Medication\n* able to swallow and retain oral medication\n* willing and able to participate in the study for the full 4 years.\n\nExclusion Criteria:\n\nA subject will not be eligible for inclusion in this study if any of the following criteria apply:\n\n* total serum PSA \\>10.0ng/mL at Screening\n* history or evidence of prostate cancer (e.g. positive biopsy or ultrasound, suspicious DRE). Patients with suspicious ultrasound or DRE who have had a negative biopsy within the preceding 6 months and stable PSA are eligible for the study.\n\nNote: If total serum PSA is \\>4ng/mL and unless PSA value has been stable for at least the past 2 years, the investigator should make every appropriate effort to exclude the possibility of prostate cancer, e.g. further DRE, review TRUS taken within previous month, consider 8-12 core prostate biopsy in accordance with routine clinical practice.\n\n* previous prostatic surgery (including TURP, balloon dilatation, thermotherapy and stent replacement) or other invasive procedures to treat BPH.\n* history of flexible/rigid cystoscopy or other instrumentation of the urethra within 7 days prior to the Screening Visit. Routine catheterisation is acceptable with no time restriction.\n* history of AUR within 3 months prior to Screening Visit.\n* post-void residual volume \\>250mL (suprapubic ultrasound) at Screening.\n* any causes other than BPH, which may in the judgement of the investigator, result in urinary symptoms or changes in flow rate (e.g. neurogenic bladder, bladder neck contracture, urethral stricture, bladder malignancy, acute or chronic prostatitis, or acute or chronic urinary tract infections).\n* history of breast cancer or clinical breast examination finding of unclear origin or suggestive of malignancy.\n* use of any 5-alpha-reductase inhibitor (e.g. Proscar®, Propecia®, Avodart®), any drugs with antiandrogenic properties (e.g. spironolactone, flutamide, bicalutamide, cimetidine, ketoconazole, metronidazole, progestational agents), or other drugs which affect prostate volume, within past 6 months of the Screening Visit and throughout the study (other than as study medication).\n* concurrent use of anabolic steroids\n* use of phytotherapy for BPH within 2 weeks of Screening Visit and/or predicted to need phytotherapy during the study.\n* use of any alpha-adrenoreceptor blockers (i.e. indoramin, prazosin, terazosin, tamsulosin, alfuzosin and doxazosin) within 2 weeks of Screening Visit and/or predicted to need any alpha blockers other than tamsulosin during the study.\n\nNote: the purpose of this criteria is to be able to standardise baseline symptom severity for all enrolled patients prior to randomisation and not to specifically exclude current alpha-adrenoreceptor blocker users from participation in the study.\n\n* use of any alpha-adrenoreceptor agonists (e.g. pseudoephedrine, phenylephrine, ephedrine) or anticholinergics (e.g. oxybutynin, propantheline) or cholinergics (e.g. bethanecol chloride) within 48 hours prior to all uroflowmetry assessments.\n* hypersensitivity to any alpha-/beta- adrenoreceptor blocker or 5-alpha-reductase inhibitor, or other chemically-related drugs.\n* concurrent use of drugs known or thought to have an interaction with tamsulosin, e.g. cimetidine and warfarin.\n* history of hepatic impairment or abnormal liver function tests at Screening defined as alanine aminotransferase (ALT), aspartate aminotranferase (AST), and/or alkaline phosphatase \\>2 times the upper limit of normal, or total bilirubin \\>1.5 times the upper limit of normal (unless associated with predominantly indirect bilirubin elevation or Gilbert's syndrome).\n* history of renal insufficiency, or serum creatinine \\>1.5 times the upper limit of normal or serum creatinine ≥1.5 mg/dL at Screening.\n* prior history of malignancies other than basal cell carcinoma or squamous cell carcinoma of the skin within the past 5 years. Subjects with a prior malignancy who have had no evidence of disease for at least the past 5 years are eligible.\n* history of any illness that in the opinion of the investigator might confound the results of the study or poses additional risk to the patient.\n* any unstable, serious co-existing medical condition(s) including, but not limited to, myocardial infarction, coronary bypass surgery, unstable angina, cardiac arrhythmias, clinically evident congestive heart failure, or cerebrovascular accident within 6 months prior to Screening visit; uncontrolled diabetes or peptic ulcer disease which is uncontrolled by medical management.\n* history of postural hypotension, dizziness, vertigo or any other signs and symptoms of orthostasis, which in the opinion of the investigator could be exacerbated by tamsulosin and result in putting the subject at risk of injury.\n* history of unsuccessful treatment with tamsulosin or 'first dose' hypotensive episode on initiation of alpha-1-adrenoreceptor antagonist therapy.\n* history of unsuccessful treatment with finasteride or dutasteride\n* history or current evidence of drug or alcohol abuse within the previous 12 months.\n* participation in any investigational or marketed drug trial within 30 days (or 5 half-lives whichever is the longer) preceding the Screening Visit and/or during the course of this study."}, 'identificationModule': {'nctId': 'NCT00090103', 'briefTitle': 'Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment', 'organization': {'class': 'INDUSTRY', 'fullName': 'GlaxoSmithKline'}, 'officialTitle': 'A Randomized, Double-blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment With Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and Combination, on the Improvement of Symptoms and Clinical Outcome in Men With Moderate to Severe Symptomatic Benign Prostatic Hyperplasia', 'orgStudyIdInfo': {'id': 'ARI40005'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'dutasteride', 'description': 'dutasteride 0.5mg once daily', 'interventionNames': ['Drug: dutasteride 0.5mg once daily for 4 years']}, {'type': 'EXPERIMENTAL', 'label': 'Combo', 'description': 'Combination of dutasteride (0.5mg) and tamsulosin (0.4mg), once daily', 'interventionNames': ['Drug: dutasteride 0.5mg once daily for 4 years', 'Drug: tamsulosin 0.4mg once daily for 4 years']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'tamsulosin', 'description': 'tamsulosin 0.4mg once daily', 'interventionNames': ['Drug: tamsulosin 0.4mg once daily for 4 years']}], 'interventions': [{'name': 'dutasteride 0.5mg once daily for 4 years', 'type': 'DRUG', 'description': 'combination or single agent', 'armGroupLabels': ['Combo', 'dutasteride']}, {'name': 'tamsulosin 0.4mg once daily for 4 years', 'type': 'DRUG', 'otherNames': ['dutasteride', 'tamsulosin'], 'description': 'combination agent or single agent', 'armGroupLabels': ['Combo', 'tamsulosin']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35209', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35234', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35242', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35294', 'city': 'Birmingham', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '35051', 'city': 'Columbiana', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.17817, 'lon': -86.60721}}, {'zip': '35216', 'city': 'Hoover', 'state': 'Alabama', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.40539, 'lon': -86.81138}}, {'zip': '99508', 'city': 'Anchorage', 'state': 'Alaska', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 61.21806, 'lon': -149.90028}}, {'zip': '85032', 'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '86106', 'city': 'Phoenix, Arizona', 'state': 'Arizona', 'country': 'United States', 'facility': 'GSK Investigational Site'}, {'zip': '90212', 'city': 'Beverly Hills', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.07362, 'lon': -118.40036}}, {'zip': '94520', 'city': 'Concord', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.97798, 'lon': -122.03107}}, {'zip': '91741', 'city': 'Glendora', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.13612, 'lon': -117.86534}}, {'zip': '94904', 'city': 'Greenbrae', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.94854, 'lon': -122.5247}}, {'zip': '92618', 'city': 'Irvine', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.66946, 'lon': -117.82311}}, {'zip': '92093', 'city': 'La Jolla', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.84727, 'lon': -117.2742}}, {'zip': '92637', 'city': 'Laguna Woods', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.6103, 'lon': -117.72533}}, {'zip': '90017', 'city': 'Los Angelas', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site'}, {'zip': '90048', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90057', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '95350', 'city': 'Modesto', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.6391, 'lon': -120.99688}}, {'zip': '95821', 'city': 'Sacramento', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.58157, 'lon': -121.4944}}, {'zip': '91405', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '92103', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '92108', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '90506', 'city': 'Torrance', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.83585, 'lon': -118.34063}}, {'zip': '92084', 'city': 'Vista', 'state': 'California', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.20004, 'lon': -117.24254}}, {'zip': '33180', 'city': 'Aventura', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.95648, 'lon': -80.13921}}, {'zip': '33744', 'city': 'Bay Pines', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 27.81419, 'lon': -82.77816}}, {'zip': '33134', 'city': 'Coral Gables', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.72149, 'lon': -80.26838}}, {'zip': '32114', 'city': 'Daytona Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.21081, 'lon': -81.02283}}, {'zip': '33461', 'city': 'Lake Worth', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.61708, 'lon': -80.07231}}, {'zip': '33156', 'city': 'Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '32168', 'city': 'New Smyrna Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.02582, 'lon': -80.927}}, {'zip': '34471', 'city': 'Ocala', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.1872, 'lon': -82.14009}}, {'zip': '32763', 'city': 'Orange City', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.94888, 'lon': -81.29867}}, {'zip': '32503', 'city': 'Pensacola', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 30.42131, 'lon': -87.21691}}, {'zip': '33156', 'city': 'Pinecrest', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.66705, 'lon': -80.30811}}, {'zip': '32086', 'city': 'Saint Augustine', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.89469, 'lon': -81.31452}}, {'zip': '34609', 'city': 'Spring Hill', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.47688, 'lon': -82.52546}}, {'zip': '33702', 'city': 'St. Petersburg', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 27.77086, 'lon': -82.67927}}, {'zip': '33710', 'city': 'St. Petersburg', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 27.77086, 'lon': -82.67927}}, {'zip': '34996', 'city': 'Stuart', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 27.19755, 'lon': -80.25283}}, {'zip': '32308', 'city': 'Tallahassee', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 30.43826, 'lon': -84.28073}}, {'zip': '33414', 'city': 'Wellington', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.65868, 'lon': -80.24144}}, {'zip': '33407', 'city': 'West Palm Beach', 'state': 'Florida', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 26.71534, 'lon': -80.05337}}, {'zip': '30342', 'city': 'Atlanta', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30513', 'city': 'Blue Ridge', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.86397, 'lon': -84.32409}}, {'zip': '30701', 'city': 'Calhoun', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 34.50259, 'lon': -84.95105}}, {'zip': '30033', 'city': 'Decatur', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.77483, 'lon': -84.29631}}, {'zip': '30066', 'city': 'Marietta', 'state': 'Georgia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.9526, 'lon': -84.54993}}, {'zip': '83642', 'city': 'Meridian', 'state': 'Idaho', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.61211, 'lon': -116.39151}}, {'zip': '62220', 'city': 'Belleville', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.52005, 'lon': -89.98399}}, {'zip': '61602', 'city': 'Peoria', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.69365, 'lon': -89.58899}}, {'zip': '61614', 'city': 'Peoria', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.69365, 'lon': -89.58899}}, {'zip': '60187', 'city': 'Wheaton', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.86614, 'lon': -88.10701}}, {'zip': '60190', 'city': 'Winfield', 'state': 'Illinois', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.8617, 'lon': -88.1609}}, {'zip': '47714', 'city': 'Evansville', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.97476, 'lon': -87.55585}}, {'zip': '47130', 'city': 'Jeffersonville', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.27757, 'lon': -85.73718}}, {'zip': '47630', 'city': 'Newburgh', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.94449, 'lon': -87.40529}}, {'zip': '46601', 'city': 'South Bend', 'state': 'Indiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.68338, 'lon': -86.25001}}, {'zip': '50309', 'city': 'Des Moines', 'state': 'Iowa', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.60054, 'lon': -93.60911}}, {'zip': '67207', 'city': 'Wichita', 'state': 'Kansas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.69224, 'lon': -97.33754}}, {'zip': '42071', 'city': 'Murray', 'state': 'Kentucky', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.61033, 'lon': -88.31476}}, {'zip': '71111', 'city': 'Bossier City', 'state': 'Louisiana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.51599, 'lon': -93.73212}}, {'zip': '20724', 'city': 'Laurel', 'state': 'Maryland', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.09928, 'lon': -76.84831}}, {'zip': '55417', 'city': 'Minneapolis', 'state': 'Minnesota', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.97997, 'lon': -93.26384}}, {'zip': '39466', 'city': 'Picayune', 'state': 'Mississippi', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 30.52556, 'lon': -89.67788}}, {'zip': '64114', 'city': 'Kansas City', 'state': 'Missouri', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '59802', 'city': 'Missoula', 'state': 'Montana', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.87215, 'lon': -113.994}}, {'zip': '68102', 'city': 'Omaha', 'state': 'Nebraska', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.25626, 'lon': -95.94043}}, {'zip': '89014', 'city': 'Henderson', 'state': 'Nevada', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.0397, 'lon': -114.98194}}, {'zip': '08844', 'city': 'Hillsborough', 'state': 'New Jersey', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4776, 'lon': -74.62682}}, {'zip': '08861', 'city': 'Perth Amboy', 'state': 'New Jersey', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.50677, 'lon': -74.26542}}, {'zip': '08876', 'city': 'Somerville', 'state': 'New Jersey', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.57427, 'lon': -74.60988}}, {'zip': '87108', 'city': 'Albuquerque', 'state': 'New Mexico', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.08449, 'lon': -106.65114}}, {'zip': '11706', 'city': 'Bay Shore', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.7251, 'lon': -73.24539}}, {'zip': '11530', 'city': 'Garden City', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.72677, 'lon': -73.6343}}, {'zip': '11021', 'city': 'Great Neck', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.80066, 'lon': -73.72846}}, {'zip': '14092', 'city': 'Lewiston', 'state': 'New York', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.17256, 'lon': -79.03588}}, {'zip': '27203', 'city': 'Asheboro', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.70791, 'lon': -79.81364}}, {'zip': '27511', 'city': 'Cary', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.79154, 'lon': -78.78112}}, {'zip': '28262', 'city': 'Charlotte', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.22709, 'lon': -80.84313}}, {'zip': '27710', 'city': 'Durham', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.99403, 'lon': -78.89862}}, {'zip': '28304', 'city': 'Fayetteville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.05266, 'lon': -78.87836}}, {'zip': '27403', 'city': 'Greensboro', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.07264, 'lon': -79.79198}}, {'zip': '28144', 'city': 'Salisbury', 'state': 'North Carolina', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.67097, 'lon': -80.47423}}, {'zip': '58501', 'city': 'Bismarck', 'state': 'North Dakota', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.80833, 'lon': -100.78374}}, {'zip': '45305', 'city': 'Bellbrook', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.63562, 'lon': -84.07077}}, {'zip': '45249', 'city': 'Cincinnati', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.12711, 'lon': -84.51439}}, {'zip': '43212', 'city': 'Columbus', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '43214', 'city': 'Columbus', 'state': 'Ohio', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '97239', 'city': 'Portland', 'state': 'Oregon', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'zip': '19522', 'city': 'Fleetwood', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.45398, 'lon': -75.81798}}, {'zip': '02904', 'city': 'Providence', 'state': 'Rhode Island', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.82399, 'lon': -71.41283}}, {'zip': '37203', 'city': 'Nashville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.16589, 'lon': -86.78444}}, {'zip': '75751', 'city': 'Athes', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site'}, {'zip': '75230', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '75234', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '75390', 'city': 'Dallas', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.78306, 'lon': -96.80667}}, {'zip': '76107', 'city': 'Fort Worth', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.72541, 'lon': -97.32085}}, {'zip': '77024', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '77030', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '78130', 'city': 'New Brunfels', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site'}, {'zip': '78229', 'city': 'San Antonio', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '76508', 'city': 'Temple', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 31.09823, 'lon': -97.34278}}, {'zip': '75503', 'city': 'Texarkana', 'state': 'Texas', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 33.42513, 'lon': -94.04769}}, {'zip': '84132', 'city': 'Salt Lake City', 'state': 'Utah', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.76078, 'lon': -111.89105}}, {'zip': '22304', 'city': 'Alexandria', 'state': 'Virginia', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.80484, 'lon': -77.04692}}, {'zip': '98004', 'city': 'Bellevue', 'state': 'Washington', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.61038, 'lon': -122.20068}}, {'zip': '98043', 'city': 'Mountlake Terrace', 'state': 'Washington', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.78815, 'lon': -122.30874}}, {'zip': '98104', 'city': 'Seattle', 'state': 'Washington', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.60621, 'lon': -122.33207}}, {'zip': '99204', 'city': 'Spokane', 'state': 'Washington', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.65966, 'lon': -117.42908}}, {'zip': '98405', 'city': 'Tacoma', 'state': 'Washington', 'country': 'United States', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.25288, 'lon': -122.44429}}, {'zip': '1120', 'city': 'Buenos Aires', 'state': 'Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site'}, {'zip': '1416', 'city': 'Buenos Aires', 'state': 'Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site'}, {'zip': '1111', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': '1405', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1181ACI', 'city': 'Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': '1118', 'city': 'Ciudad de Buenos Aires', 'country': 'Argentina', 'facility': 'GSK Investigational Site'}, {'zip': '2020', 'city': 'Antwerp', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.22047, 'lon': 4.40026}}, {'zip': '1070', 'city': 'Brussels', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'zip': '1090', 'city': 'Brussels', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'zip': '2650', 'city': 'Edegem', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.15662, 'lon': 4.44504}}, {'zip': '3600', 'city': 'Genk', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.965, 'lon': 5.50082}}, {'zip': '7100', 'city': 'La Louvière', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.48657, 'lon': 4.18785}}, {'zip': '4000', 'city': 'Liège', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.63373, 'lon': 5.56749}}, {'zip': '8800', 'city': 'Roeselare', 'country': 'Belgium', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.94653, 'lon': 3.12269}}, {'zip': '30130-008', 'city': 'Belo Horizonte', 'state': 'Minas Gerais', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -19.92083, 'lon': -43.93778}}, {'zip': '20 551-030', 'city': 'Rio de Janeiro', 'state': 'Rio de Janeiro', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -22.90642, 'lon': -43.18223}}, {'zip': '90035-903', 'city': 'Porto Alegre', 'state': 'Rio Grande do Sul', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -30.03283, 'lon': -51.23019}}, {'zip': '90470-340', 'city': 'Porto Alegre', 'state': 'Rio Grande do Sul', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -30.03283, 'lon': -51.23019}}, {'zip': '90610-000', 'city': 'Porto Alegre', 'state': 'Rio Grande do Sul', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -30.03283, 'lon': -51.23019}}, {'zip': '04262-000', 'city': 'São Paulo', 'state': 'São Paulo', 'country': 'Brazil', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -23.5475, 'lon': -46.63611}}, {'zip': '5800', 'city': 'Pleven', 'country': 'Bulgaria', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.41791, 'lon': 24.61666}}, {'zip': '1000', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1431/1000', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '1606', 'city': 'Sofia', 'country': 'Bulgaria', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.69751, 'lon': 23.32415}}, {'zip': '9002', 'city': 'Varna', 'country': 'Bulgaria', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.21912, 'lon': 27.91024}}, {'zip': 'V3V 1N1', 'city': 'Surrey', 'state': 'British Columbia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.10635, 'lon': -122.82509}}, {'zip': 'R3C 0N2', 'city': 'Winnipeg', 'state': 'Manitoba', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.8844, 'lon': -97.14704}}, {'zip': 'E2L 4L2', 'city': 'Saint John', 'state': 'New Brunswick', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.27076, 'lon': -66.05616}}, {'zip': 'A1B 4S8', 'city': "St. John's", 'state': 'Newfoundland and Labrador', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.56494, 'lon': -52.70931}}, {'zip': 'B3H 3A7', 'city': 'Halifax', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.64269, 'lon': -63.57688}}, {'zip': 'B4N 4K9', 'city': 'Kentville', 'state': 'Nova Scotia', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.0771, 'lon': -64.49605}}, {'zip': 'L4M 7G1', 'city': 'Barrie', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.40011, 'lon': -79.66634}}, {'zip': 'N3R 4N3', 'city': 'Brantford', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.1334, 'lon': -80.26636}}, {'zip': 'L1E 3C3', 'city': 'Courtice', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.91682, 'lon': -78.76626}}, {'zip': 'P3E 4T3', 'city': 'Greater Sudbury', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.49, 'lon': -80.99001}}, {'zip': 'N1H 5J1', 'city': 'Guelph', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.54594, 'lon': -80.25599}}, {'zip': 'L8N 4A6', 'city': 'Hamilton', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.25011, 'lon': -79.84963}}, {'zip': 'K7L 2V7', 'city': 'Kingston', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.22976, 'lon': -76.48098}}, {'zip': 'M6A 4G5', 'city': 'London', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'N6A 4V2', 'city': 'London', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'P1B 7K8', 'city': 'North Bay', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.3168, 'lon': -79.46633}}, {'zip': 'L6H 3P1', 'city': 'Oakville', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.45011, 'lon': -79.68292}}, {'zip': 'L1H 7K4', 'city': 'Oshawa', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.90012, 'lon': -78.84957}}, {'zip': 'K1Y 4E9', 'city': 'Ottawa', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.41117, 'lon': -75.69812}}, {'zip': 'M1P 2T7', 'city': 'Scarborough Village', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.73899, 'lon': -79.22124}}, {'zip': 'M1S 4V5', 'city': 'Scarborough Village', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.73899, 'lon': -79.22124}}, {'zip': 'M2K 2W1', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M4C 5T2', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M5T 2S8', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M6A 3B5', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'M6S 4W4', 'city': 'Toronto', 'state': 'Ontario', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'H2X 1N8', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H3A 1A1', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H3S 1Z1', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'J6E 6J2', 'city': 'Saint-Charles-Borromée', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.05007, 'lon': -73.46586}}, {'zip': 'J7Z 5T3', 'city': 'Saint-Jérôme', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.78036, 'lon': -74.00365}}, {'zip': 'J1H 5N4', 'city': 'Sherbrooke', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'zip': 'G9A 3V7', 'city': 'Trois-Rivières', 'state': 'Quebec', 'country': 'Canada', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.34515, 'lon': -72.5477}}, {'zip': '536 00', 'city': 'Hradec Králové', 'country': 'Czechia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.20923, 'lon': 15.83277}}, {'zip': '708 52', 'city': 'Ostrava - Poruba', 'country': 'Czechia', 'facility': 'GSK Investigational Site'}, {'zip': '130 00', 'city': 'Prague', 'country': 'Czechia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '150 18', 'city': 'Prague', 'country': 'Czechia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '180 71', 'city': 'Prague', 'country': 'Czechia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '413 01', 'city': 'Roudnice nad Labem', 'country': 'Czechia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.42528, 'lon': 14.26175}}, {'zip': '9100', 'city': 'Aalborg', 'country': 'Denmark', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 57.048, 'lon': 9.9187}}, {'zip': '8200', 'city': 'Aarhus N', 'country': 'Denmark', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 56.20367, 'lon': 10.17317}}, {'zip': '7000', 'city': 'Fredericia', 'country': 'Denmark', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.56568, 'lon': 9.75257}}, {'zip': '8900', 'city': 'Randers', 'country': 'Denmark', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 56.4607, 'lon': 10.03639}}, {'zip': '1162', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '13419', 'city': 'Tallinn', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.43696, 'lon': 24.75353}}, {'zip': '51014', 'city': 'Tartu', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 58.38062, 'lon': 26.72509}}, {'city': 'Tartu', 'country': 'Estonia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 58.38062, 'lon': 26.72509}}, {'zip': '00150', 'city': 'Helsinki', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.16952, 'lon': 24.93545}}, {'zip': '68600', 'city': 'Jakobstad', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 63.67486, 'lon': 22.70256}}, {'zip': '45200', 'city': 'Kouvola', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.86667, 'lon': 26.7}}, {'zip': '70100', 'city': 'Kuopio', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 62.89238, 'lon': 27.67703}}, {'zip': '33520', 'city': 'Tampere', 'country': 'Finland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 61.49911, 'lon': 23.78712}}, {'zip': '62160', 'city': 'Bully-les-Mines', 'state': 'Hauts-de-France', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.4438, 'lon': 2.72703}}, {'zip': '62217', 'city': 'Agny', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.25914, 'lon': 2.76002}}, {'zip': '49000', 'city': 'Angers', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.47156, 'lon': -0.55202}}, {'zip': '74000', 'city': 'Annecy', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.90878, 'lon': 6.12565}}, {'zip': '62000', 'city': 'Arras', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.29301, 'lon': 2.78186}}, {'zip': '91200', 'city': 'Athis-Mons', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.70522, 'lon': 2.39147}}, {'zip': '25000', 'city': 'Besançon', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.24878, 'lon': 6.01815}}, {'zip': '49080', 'city': 'Bouchemaine', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.42234, 'lon': -0.60888}}, {'zip': '27270', 'city': 'Broglie', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.00911, 'lon': 0.52915}}, {'zip': '34170', 'city': 'Castelneau Le Nez', 'country': 'France', 'facility': 'GSK Investigational Site'}, {'zip': '73000', 'city': 'Chambéry', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.56628, 'lon': 5.92079}}, {'zip': '91380', 'city': 'Chilly-Mazarin', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.71489, 'lon': 2.31638}}, {'zip': '34460', 'city': 'Cournonterral', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.55889, 'lon': 3.72}}, {'zip': '94010', 'city': 'Créteil', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.79266, 'lon': 2.46569}}, {'zip': '38300', 'city': 'Domarin', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.58662, 'lon': 5.24599}}, {'zip': '91360', 'city': 'Épinay-sur-Orge', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.67338, 'lon': 2.31074}}, {'zip': '27000', 'city': 'Évreux', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.02414, 'lon': 1.15082}}, {'zip': '27025', 'city': 'Évreux', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.02414, 'lon': 1.15082}}, {'zip': '91190', 'city': 'Gif-sur-Yvette', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.68333, 'lon': 2.13333}}, {'zip': '38100', 'city': 'Grenoble', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.17869, 'lon': 5.71479}}, {'zip': '83500', 'city': 'La Seyne-sur-Mer', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.10322, 'lon': 5.87816}}, {'zip': '33460', 'city': 'Lamarque', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.09615, 'lon': -0.71771}}, {'zip': '53000', 'city': 'Laval', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.07247, 'lon': -0.77019}}, {'zip': '83140', 'city': 'Le Brusc', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.074, 'lon': 5.803}}, {'zip': '94275', 'city': 'Le Kremlin-Bicêtre', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.81471, 'lon': 2.36073}}, {'zip': '78130', 'city': 'Les Mureaux', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.99173, 'lon': 1.90972}}, {'zip': '33340', 'city': 'Lesparre-Médoc', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.30709, 'lon': -0.93793}}, {'zip': '91310', 'city': 'Linas', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.63041, 'lon': 2.26266}}, {'zip': '91310', 'city': 'Longpont-sur-Orge', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.64171, 'lon': 2.29278}}, {'zip': '69008', 'city': 'Lyon', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'zip': '77007', 'city': 'Melun', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.5457, 'lon': 2.65356}}, {'zip': '92190', 'city': 'Meudon', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.81381, 'lon': 2.235}}, {'zip': '38240', 'city': 'Meylan', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.20978, 'lon': 5.77762}}, {'zip': '40000', 'city': 'Mont-de-Marsan', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.89022, 'lon': -0.49713}}, {'zip': '82017', 'city': 'Montauban', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.01759, 'lon': 1.3542}}, {'zip': '34000', 'city': 'Montpelier', 'country': 'France', 'facility': 'GSK Investigational Site'}, {'zip': '34000', 'city': 'Montpellier', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.61093, 'lon': 3.87635}}, {'zip': '34100', 'city': 'Montpellier', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.61093, 'lon': 3.87635}}, {'zip': '45067', 'city': 'Orléans', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.90248, 'lon': 1.90407}}, {'zip': '75019', 'city': 'Paris', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}, {'zip': '40465', 'city': 'Pontonx Sur Adour', 'country': 'France', 'facility': 'GSK Investigational Site'}, {'zip': '42300', 'city': 'Roanne', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.03624, 'lon': 4.06802}}, {'zip': '42400', 'city': 'Saint-Chamond', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.4759, 'lon': 4.51294}}, {'zip': '93200', 'city': 'Saint-Denis', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.93564, 'lon': 2.35387}}, {'zip': '38120', 'city': 'Saint-Egrève', 'country': 'France', 'facility': 'GSK Investigational Site'}, {'zip': '42330', 'city': 'Saint-Galmier', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.59787, 'lon': 4.31086}}, {'zip': '34680', 'city': 'Saint-Georges-dOrques', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.61139, 'lon': 3.78139}}, {'zip': '42640', 'city': 'Saint-Germain-Lespinasse', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.10342, 'lon': 3.96503}}, {'zip': '27180', 'city': 'Saint-Sébastien-de-Morsent', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.01096, 'lon': 1.0873}}, {'zip': '53270', 'city': 'Sainte-Suzanne', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.50017, 'lon': 6.76775}}, {'zip': '83110', 'city': 'Sanary-sur-Mer', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.11985, 'lon': 5.80155}}, {'zip': '24200', 'city': 'Sarlat-la-Canéda', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.88902, 'lon': 1.21656}}, {'zip': '31600', 'city': 'Seysses', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.49801, 'lon': 1.31081}}, {'zip': '83140', 'city': 'Six-Fours-les-Plages', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.09174, 'lon': 5.82465}}, {'zip': '92151', 'city': 'Suresnes', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.87143, 'lon': 2.22929}}, {'zip': '83200', 'city': 'Toulon', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.12442, 'lon': 5.92836}}, {'zip': '37044', 'city': 'Tours', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.39484, 'lon': 0.70398}}, {'zip': '92420', 'city': 'Vaucresson', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.84078, 'lon': 2.15652}}, {'zip': '78480', 'city': 'Verneuil-sur-Seine', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.97388, 'lon': 1.9648}}, {'zip': '94804', 'city': 'Villejuif', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.7939, 'lon': 2.35992}}, {'zip': '34750', 'city': 'Villeneuve-lès-Maguelone', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.53222, 'lon': 3.86047}}, {'zip': '38210', 'city': 'Vourey', 'country': 'France', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.3218, 'lon': 5.51931}}, {'zip': '73430', 'city': 'Aalen', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.83777, 'lon': 10.0933}}, {'zip': '79106', 'city': 'Freiburg im Breisgau', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.9959, 'lon': 7.85222}}, {'zip': '78464', 'city': 'Konstanz', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.66033, 'lon': 9.17582}}, {'zip': '74821', 'city': 'Mosbach', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.35357, 'lon': 9.15106}}, {'zip': '78628', 'city': 'Rottweil', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.16783, 'lon': 8.62719}}, {'zip': '78333', 'city': 'Stockach', 'state': 'Baden-Wurttemberg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.85105, 'lon': 9.0091}}, {'zip': '86551', 'city': 'Aichach', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.45755, 'lon': 11.13413}}, {'zip': '92224', 'city': 'Amberg', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.44287, 'lon': 11.86267}}, {'zip': '86150', 'city': 'Augsburg', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.37154, 'lon': 10.89851}}, {'zip': '82166', 'city': 'Graefeling', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site'}, {'zip': '89231', 'city': 'Neu-Ulm', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.39279, 'lon': 10.01112}}, {'zip': '86956', 'city': 'Schongau', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.8124, 'lon': 10.89664}}, {'zip': '86637', 'city': 'Wertingen', 'state': 'Bavaria', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.56314, 'lon': 10.68149}}, {'zip': '19230', 'city': 'Hagenow', 'state': 'Brandenburg', 'country': 'Germany', 'facility': 'GSK Investigational Site'}, {'zip': '01979', 'city': 'Lauchhammer', 'state': 'Brandenburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.48813, 'lon': 13.76623}}, {'zip': '16515', 'city': 'Oranienburg', 'state': 'Brandenburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.75577, 'lon': 13.24197}}, {'zip': '01968', 'city': 'Senftenberg', 'state': 'Brandenburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.52517, 'lon': 14.00164}}, {'zip': '20253', 'city': 'Hamburg', 'state': 'Hamburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '22415', 'city': 'Hamburg', 'state': 'Hamburg', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '63755', 'city': 'Alzenau', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site'}, {'zip': '60326', 'city': 'Frankfurt am Main', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.11552, 'lon': 8.68417}}, {'zip': '36037', 'city': 'Fulda', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.55162, 'lon': 9.67518}}, {'zip': '35390', 'city': 'Giessen', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.58727, 'lon': 8.67554}}, {'zip': '34123', 'city': 'Kassel', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.31667, 'lon': 9.5}}, {'zip': '61462', 'city': 'Koenigstein', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site'}, {'zip': '35039', 'city': 'Marburg', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.80904, 'lon': 8.77069}}, {'zip': '65824', 'city': 'Schwalbach', 'state': 'Hesse', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.49672, 'lon': 8.46943}}, {'zip': '27753', 'city': 'Delmenhorst', 'state': 'Lower Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.0511, 'lon': 8.63091}}, {'zip': '37603', 'city': 'Holzminden', 'state': 'Lower Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.82798, 'lon': 9.4455}}, {'zip': '26121', 'city': 'Oldenburg', 'state': 'Lower Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.14039, 'lon': 8.21479}}, {'zip': '49074', 'city': 'Osnabrück', 'state': 'Lower Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.27264, 'lon': 8.0498}}, {'zip': '18507', 'city': 'Grimmen', 'state': 'Mecklenburg-Vorpommern', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.11215, 'lon': 13.04051}}, {'zip': '19370', 'city': 'Parchim', 'state': 'Mecklenburg-Vorpommern', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.42631, 'lon': 11.84875}}, {'zip': '48249', 'city': 'Dülmen', 'state': 'North Rhine-Westphalia', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.83149, 'lon': 7.28075}}, {'zip': '48703', 'city': 'Stadtlohn', 'state': 'North Rhine-Westphalia', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.99399, 'lon': 6.91918}}, {'zip': '56068', 'city': 'Koblenz', 'state': 'Rhineland-Palatinate', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.35357, 'lon': 7.57883}}, {'zip': '09337', 'city': 'Hohenstein-Ernsttal', 'state': 'Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site'}, {'zip': '04105', 'city': 'Leipzig', 'state': 'Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '04109', 'city': 'Leipzig', 'state': 'Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '04277', 'city': 'Leipzig', 'state': 'Saxony', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '06114', 'city': 'Halle', 'state': 'Saxony-Anhalt', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.48158, 'lon': 11.97947}}, {'zip': '06333', 'city': 'Hettstedt', 'state': 'Saxony-Anhalt', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.6503, 'lon': 11.51146}}, {'zip': '06217', 'city': 'Merseburg', 'state': 'Saxony-Anhalt', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.35478, 'lon': 11.98923}}, {'zip': '25813', 'city': 'Husum', 'state': 'Schleswig-Holstein', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.4858, 'lon': 9.05239}}, {'zip': '24103', 'city': 'Kiel', 'state': 'Schleswig-Holstein', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.32133, 'lon': 10.13489}}, {'zip': '10627', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '10719', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12167', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12347', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '12681', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13053', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13055', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13125', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13439', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '14197', 'city': 'Berlin', 'state': 'State of Berlin', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '99510', 'city': 'Apolda', 'state': 'Thuringia', 'country': 'Germany', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.02624, 'lon': 11.51638}}, {'zip': '115 21', 'city': 'Athens', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '115 22', 'city': 'Athens', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '15126', 'city': 'Athens', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '154 52', 'city': 'Athens', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '265 00', 'city': 'Pátrai', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.2462, 'lon': 21.73508}}, {'zip': '63 100', 'city': 'Polygyros', 'country': 'Greece', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.37704, 'lon': 23.44135}}, {'zip': '564 34', 'city': 'Thassaloniki', 'country': 'Greece', 'facility': 'GSK Investigational Site'}, {'zip': '1036.', 'city': 'Budapest', 'country': 'Hungary', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'zip': '9400', 'city': 'Sopron', 'country': 'Hungary', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.68501, 'lon': 16.59049}}, {'zip': '8000', 'city': 'Székesfehérvár', 'country': 'Hungary', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.18995, 'lon': 18.41034}}, {'zip': '8200', 'city': 'Veszprém', 'country': 'Hungary', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.09327, 'lon': 17.91149}}, {'zip': '101', 'city': 'Reykjavik', 'country': 'Iceland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 64.13548, 'lon': -21.89541}}, {'zip': '31048', 'city': 'Haifa', 'country': 'Israel', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.81303, 'lon': 34.99928}}, {'city': 'Haifa', 'country': 'Israel', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.81303, 'lon': 34.99928}}, {'zip': '58100', 'city': 'Holon', 'country': 'Israel', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.01034, 'lon': 34.77918}}, {'zip': '44281', 'city': 'Kfar Saba', 'country': 'Israel', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.175, 'lon': 34.90694}}, {'zip': '52621', 'city': 'Ramat Gan', 'country': 'Israel', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 32.08227, 'lon': 34.81065}}, {'zip': '70300', 'city': 'Zrifin', 'country': 'Israel', 'facility': 'GSK Investigational Site'}, {'zip': '88100', 'city': 'Catanzaro', 'state': 'Calabria', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.88247, 'lon': 16.60086}}, {'zip': '83100', 'city': 'Avellino', 'state': 'Campania', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.91494, 'lon': 14.79103}}, {'zip': '80053', 'city': 'Castellamare Di Stabia (NA)', 'state': 'Campania', 'country': 'Italy', 'facility': 'GSK Investigational Site'}, {'zip': '80131', 'city': 'Napoli', 'state': 'Campania', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.87618, 'lon': 14.5195}}, {'zip': '81027', 'city': 'San Felice A Cancello Caserta', 'state': 'Campania', 'country': 'Italy', 'facility': 'GSK Investigational Site'}, {'zip': '80059', 'city': 'Torre Del Greco (NA)', 'state': 'Campania', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.78931, 'lon': 14.36806}}, {'zip': '41100', 'city': 'Modena', 'state': 'Emilia-Romagna', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.64783, 'lon': 10.92539}}, {'zip': '33100', 'city': 'Udine', 'state': 'Friuli Venezia Giulia', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.0693, 'lon': 13.23715}}, {'zip': '00189', 'city': 'Rome', 'state': 'Lazio', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.89193, 'lon': 12.51133}}, {'zip': '16128', 'city': 'Genoa', 'state': 'Liguria', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.40478, 'lon': 8.94439}}, {'zip': '23100', 'city': 'Lecco', 'state': 'Lombardy', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.85589, 'lon': 9.39704}}, {'zip': '20132', 'city': 'Milan', 'state': 'Lombardy', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.46427, 'lon': 9.18951}}, {'zip': '10015', 'city': 'Ivrea (TO)', 'state': 'Piedmont', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.46723, 'lon': 7.87617}}, {'zip': '28100', 'city': 'Novara', 'state': 'Piedmont', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.44694, 'lon': 8.62118}}, {'zip': '10126', 'city': 'Turin', 'state': 'Piedmont', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.07049, 'lon': 7.68682}}, {'zip': '09134', 'city': 'Cagliari', 'state': 'Sardinia', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.23054, 'lon': 9.11917}}, {'zip': '95124', 'city': 'Acireale (CT)', 'state': 'Sicily', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.60886, 'lon': 15.16577}}, {'zip': '50126', 'city': 'Bagno A Ripoli (FI)', 'state': 'Tuscany', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.75115, 'lon': 11.32252}}, {'zip': '50139', 'city': 'Florence', 'state': 'Tuscany', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.77925, 'lon': 11.24626}}, {'zip': '53100', 'city': 'Siena', 'state': 'Tuscany', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.31822, 'lon': 11.33064}}, {'zip': '30026', 'city': 'Portogruaro (VE)', 'state': 'Veneto', 'country': 'Italy', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.78071, 'lon': 12.84052}}, {'zip': 'LT-47144', 'city': 'Kaunas', 'country': 'Lithuania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.90156, 'lon': 23.90909}}, {'zip': 'LT-49287', 'city': 'Kaunas', 'country': 'Lithuania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.90156, 'lon': 23.90909}}, {'zip': 'LT-92231', 'city': 'Klaipėda', 'country': 'Lithuania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.7068, 'lon': 21.13912}}, {'zip': 'LT-92288', 'city': 'Klaipėda', 'country': 'Lithuania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.7068, 'lon': 21.13912}}, {'zip': 'LT-10207', 'city': 'Vilnius', 'country': 'Lithuania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.68916, 'lon': 25.2798}}, {'zip': '44340', 'city': 'Guadalajara', 'state': 'Jalisco', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 20.67738, 'lon': -103.34749}}, {'zip': '45170', 'city': 'Zapopan', 'state': 'Jalisco', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 20.72111, 'lon': -103.38742}}, {'zip': '45100', 'city': 'Zapopan, Jalisco', 'state': 'Jalisco', 'country': 'Mexico', 'facility': 'GSK Investigational Site'}, {'zip': '06720', 'city': 'Mexico City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 19.42847, 'lon': -99.12766}}, {'zip': '14050', 'city': 'Mexico City', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 19.42847, 'lon': -99.12766}}, {'zip': '06700', 'city': 'México', 'country': 'Mexico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 31.00435, 'lon': -108.15213}}, {'zip': '1815 JD', 'city': 'Alkmaar', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.63167, 'lon': 4.74861}}, {'zip': '1186 AM', 'city': 'Amstelveen', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.30083, 'lon': 4.86389}}, {'zip': '1034 CS', 'city': 'Amsterdam', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'zip': '1105 AZ', 'city': 'Amsterdam', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'zip': '6842 CV', 'city': 'Arnhem', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.98, 'lon': 5.91111}}, {'zip': '7009 BL', 'city': 'Doetinchem', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.965, 'lon': 6.28889}}, {'zip': '7511JX', 'city': 'Enschede', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.21833, 'lon': 6.89583}}, {'zip': '4872 LA', 'city': 'Etten-Leur', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.57056, 'lon': 4.63726}}, {'zip': '9713 GZ', 'city': 'Groningen', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.21917, 'lon': 6.56667}}, {'zip': '9721 SW', 'city': 'Groningen', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.21917, 'lon': 6.56667}}, {'zip': '6419 PC', 'city': 'Heerlen', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.88365, 'lon': 5.98154}}, {'zip': '1213 XZ', 'city': 'Hilversum', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.22333, 'lon': 5.17639}}, {'zip': '2134 TM', 'city': 'Hoofddorp', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.3025, 'lon': 4.68889}}, {'zip': '6229 HX', 'city': 'Maastricht', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.84833, 'lon': 5.68889}}, {'zip': '2566 MJ', 'city': 'The Hague', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 52.07667, 'lon': 4.29861}}, {'zip': '5022 GC', 'city': 'Tilburg', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.55551, 'lon': 5.0913}}, {'zip': '5042 AD', 'city': 'Tilburg', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.55551, 'lon': 5.0913}}, {'zip': '5504 DB', 'city': 'Veldhoven', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.41833, 'lon': 5.40278}}, {'zip': '7101 BN', 'city': 'Winterswijk', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.9725, 'lon': 6.71944}}, {'zip': '3331 LZ', 'city': 'Zwijndrecht', 'country': 'Netherlands', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.8175, 'lon': 4.63333}}, {'zip': 'N-6026', 'city': 'Ålesund', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 62.47225, 'lon': 6.15492}}, {'zip': '5094', 'city': 'Bergen', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.39299, 'lon': 5.32415}}, {'zip': 'N-8009', 'city': 'Bodø', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 67.28267, 'lon': 14.37513}}, {'zip': '5507', 'city': 'Haugesund', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.41378, 'lon': 5.268}}, {'zip': 'N-2390', 'city': 'Moelv', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 60.93333, 'lon': 10.7}}, {'zip': '3128', 'city': 'Nøtterøy', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.23333, 'lon': 10.4}}, {'zip': '0257 OSLO', 'city': 'Oslo', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.91273, 'lon': 10.74609}}, {'zip': '0514', 'city': 'Oslo', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.91273, 'lon': 10.74609}}, {'zip': 'N-3922', 'city': 'Porsgrunn', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.14054, 'lon': 9.6561}}, {'zip': '3116', 'city': 'Tønsberg', 'country': 'Norway', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.26754, 'lon': 10.40762}}, {'zip': '1003', 'city': 'Manila', 'country': 'Philippines', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 14.6042, 'lon': 120.9822}}, {'zip': '1101', 'city': 'Quezon City', 'country': 'Philippines', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 14.6488, 'lon': 121.0509}}, {'zip': '80-402', 'city': 'Gdansk', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.35227, 'lon': 18.64912}}, {'zip': '31-221', 'city': 'Krakow', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'zip': '31-826', 'city': 'Krakow', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.06143, 'lon': 19.93658}}, {'zip': '20-950', 'city': 'Lublin', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.25058, 'lon': 22.57009}}, {'zip': '50-043', 'city': 'Wroclaw', 'country': 'Poland', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.10286, 'lon': 17.03006}}, {'zip': '2200 Abrantes', 'city': 'Abrantes', 'country': 'Portugal', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.46667, 'lon': -8.2}}, {'zip': '1069-166', 'city': 'Lisbon', 'country': 'Portugal', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'zip': '1269-098 Lisboa', 'city': 'Lisbon', 'country': 'Portugal', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.72509, 'lon': -9.1498}}, {'zip': '4099-004', 'city': 'Porto', 'country': 'Portugal', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.1485, 'lon': -8.61097}}, {'zip': '4150-113 PORTO', 'city': 'Porto', 'country': 'Portugal', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.1485, 'lon': -8.61097}}, {'zip': '3040-316 Coimbra', 'city': 'S. Martinho Do Bispo', 'country': 'Portugal', 'facility': 'GSK Investigational Site'}, {'zip': '00716', 'city': 'Ponce', 'state': 'Puerto Rico', 'country': 'Puerto Rico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 18.01031, 'lon': -66.62398}}, {'zip': '00907', 'city': 'Santurce', 'state': 'Puerto Rico', 'country': 'Puerto Rico', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 18.19523, 'lon': -67.14018}}, {'zip': '310175', 'city': 'Arad', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.18333, 'lon': 21.31667}}, {'zip': '022328', 'city': 'Bucharest', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'city': 'Bucharest', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'city': 'Cluj-Napoca', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 46.76667, 'lon': 23.6}}, {'city': 'Iași', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.16667, 'lon': 27.6}}, {'city': 'Timișoara', 'country': 'Romania', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 45.75372, 'lon': 21.22571}}, {'zip': '105229', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '109472', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '117 837', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '125206', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'zip': '125367', 'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'city': 'Moscow', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.75204, 'lon': 37.61781}}, {'city': 'Rostov-on-Don', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 47.21997, 'lon': 39.70769}}, {'city': 'Saint Petersburg', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 59.93863, 'lon': 30.31413}}, {'city': 'Smolensk', 'country': 'Russia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 54.77826, 'lon': 32.05088}}, {'zip': '975 17', 'city': 'Banská Bystrica', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.73947, 'lon': 19.14932}}, {'zip': '813 69', 'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'zip': '833 05', 'city': 'Bratislava', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.14816, 'lon': 17.10674}}, {'zip': '041 66', 'city': 'Košice', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.71441, 'lon': 21.25802}}, {'zip': '036 59', 'city': 'Martin', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.06651, 'lon': 18.92399}}, {'zip': '909 01', 'city': 'Skalica', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 48.8449, 'lon': 17.22635}}, {'zip': '010 01', 'city': 'Žilina', 'country': 'Slovakia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 49.22315, 'lon': 18.73941}}, {'zip': '8001', 'city': 'Cape Town', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -33.92584, 'lon': 18.42322}}, {'zip': '7700', 'city': 'Claremont', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -33.98056, 'lon': 18.46528}}, {'zip': '7130', 'city': 'Somerset West', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -34.08401, 'lon': 18.82113}}, {'zip': '2157', 'city': 'Sunninghill', 'country': 'South Africa', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': -26.0355, 'lon': 28.06552}}, {'zip': '602-739', 'city': 'Pusan', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.3809, 'lon': 128.3681}}, {'zip': '135-710', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '135-720', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '138-736', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '150-015', 'city': 'Seoul', 'country': 'South Korea', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '15006', 'city': 'A Coruña', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.37135, 'lon': -8.396}}, {'zip': '01004', 'city': 'Alava', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.36057, 'lon': -6.19946}}, {'zip': '13600', 'city': 'Alcázar de San Juan (Ciudad Real)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.39011, 'lon': -3.20827}}, {'zip': '6080', 'city': 'Badajoz', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.87789, 'lon': -6.97061}}, {'zip': '08022', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08025', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08221', 'city': 'Barcelona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '09005', 'city': 'Burgos', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.34106, 'lon': -3.70184}}, {'zip': '13005', 'city': 'Ciudad Real', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.98626, 'lon': -3.92907}}, {'zip': '20012', 'city': 'Donostia / San Sebastian', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.31283, 'lon': -1.97499}}, {'zip': '03202', 'city': 'Elche (Alicante)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.26218, 'lon': -0.70107}}, {'zip': '33394', 'city': 'Gijón', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.53573, 'lon': -5.66152}}, {'zip': '19002', 'city': 'Guadalajara', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.62862, 'lon': -3.16185}}, {'zip': '11407', 'city': 'Jerez de la Frontera', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.68645, 'lon': -6.13606}}, {'zip': '33920', 'city': 'Langreo (Oviedo)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.29568, 'lon': -5.68416}}, {'zip': '35020', 'city': 'Las Palmas', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.58232, 'lon': -16.16555}}, {'zip': '35016', 'city': 'Las Palmas de Gran Canaria', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.10178, 'lon': -15.41573}}, {'zip': '28006', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28016', 'city': 'Madrid', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'city': 'Manacor (Palma de Mallorca)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.56964, 'lon': 3.20955}}, {'zip': '29600', 'city': 'Marbella', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.51543, 'lon': -4.88583}}, {'zip': '29020', 'city': 'Málaga', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.72016, 'lon': -4.42034}}, {'zip': '20850', 'city': 'Mendaro, Guipuzcoa', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.25326, 'lon': -2.38568}}, {'zip': '6800', 'city': 'Mérida', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.91802, 'lon': -6.34292}}, {'zip': '30008', 'city': 'Murcia', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 37.98704, 'lon': -1.13004}}, {'zip': '07014', 'city': 'Palma de Mallorca', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.56939, 'lon': 2.65024}}, {'zip': '31008', 'city': 'Pamplona', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.81687, 'lon': -1.64323}}, {'zip': '36071', 'city': 'Pontevedra', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.431, 'lon': -8.64435}}, {'zip': '08208', 'city': 'Sabadell (Barcelona)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.54329, 'lon': 2.10942}}, {'zip': '20014', 'city': 'San Sebastián', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.56667, 'lon': -5.9}}, {'zip': '38010', 'city': 'Santa Cruz de Tenerife', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 28.46824, 'lon': -16.25462}}, {'zip': '38008', 'city': 'Santander', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.46589, 'lon': -3.80493}}, {'city': 'Santander', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 43.46589, 'lon': -3.80493}}, {'zip': '15706', 'city': 'Santiago de Compostela', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.88052, 'lon': -8.54569}}, {'zip': '43500', 'city': 'Tortosa', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 40.81249, 'lon': 0.5216}}, {'zip': '46009', 'city': 'Valencia', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'zip': '30211', 'city': 'Vigo (Pontevedra)', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.23282, 'lon': -8.72264}}, {'zip': '36200', 'city': 'Vigo/Pontevedra', 'country': 'Spain', 'facility': 'GSK Investigational Site'}, {'zip': '01009', 'city': 'Vitoria-Gasteiz', 'country': 'Spain', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 42.84998, 'lon': -2.67268}}, {'zip': '48902', 'city': 'Vizcaya', 'country': 'Spain', 'facility': 'GSK Investigational Site'}, {'zip': '813', 'city': 'Kaohsiung City', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 22.61626, 'lon': 120.31333}}, {'zip': '404', 'city': 'Taichung', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 24.1469, 'lon': 120.6839}}, {'zip': '704', 'city': 'Tainan', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 22.99083, 'lon': 120.21333}}, {'zip': '100', 'city': 'Taipei', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '112', 'city': 'Taipei', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '114', 'city': 'Taipei', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '333', 'city': 'Taoyuan District', 'country': 'Taiwan', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 24.9896, 'lon': 121.3187}}, {'zip': '10330', 'city': 'Bangkok', 'country': 'Thailand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'zip': '10400', 'city': 'Bangkok', 'country': 'Thailand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'zip': '10700', 'city': 'Bangkok', 'country': 'Thailand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 13.75398, 'lon': 100.50144}}, {'zip': '50200', 'city': 'Chiang Mai', 'country': 'Thailand', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 18.79038, 'lon': 98.98468}}, {'zip': '4054', 'city': 'Sousse', 'country': 'Tunisia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 35.82539, 'lon': 10.63699}}, {'zip': '1007', 'city': 'Tunis', 'country': 'Tunisia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.81897, 'lon': 10.16579}}, {'zip': '1008', 'city': 'Tunis', 'country': 'Tunisia', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 36.81897, 'lon': 10.16579}}, {'zip': '34303', 'city': 'Istanbul', 'country': 'Turkey (Türkiye)', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 41.01384, 'lon': 28.94966}}, {'zip': '35100', 'city': 'Izmir', 'country': 'Turkey (Türkiye)', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'zip': '06100', 'city': 'Sıhhiye/Ankara', 'country': 'Turkey (Türkiye)', 'facility': 'GSK Investigational Site'}, {'zip': 'SA4 4NU', 'city': 'Swansea', 'state': 'Glamorgan', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.62079, 'lon': -3.94323}}, {'zip': 'PR7 7NA', 'city': 'Buckshaw Village, Chorley', 'state': 'Lancashire', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.65, 'lon': -2.61667}}, {'zip': 'HA6 2RN', 'city': 'Northwood', 'state': 'Middlesex', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.61162, 'lon': -0.42454}}, {'zip': 'EH4 2XU', 'city': 'Edinburgh', 'state': 'Midlothian', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 55.95206, 'lon': -3.19648}}, {'zip': 'OX2 6PD', 'city': 'Oxford', 'state': 'Oxfordshire', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 51.75222, 'lon': -1.25596}}, {'zip': 'PO19 4SE', 'city': 'Chichester', 'state': 'Sussex West', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 50.83673, 'lon': -0.78003}}, {'zip': 'G81 2DR', 'city': 'Clydebank, Glasgow', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site'}, {'zip': 'DD1 9SY', 'city': 'Dundee', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 56.46913, 'lon': -2.97489}}, {'zip': 'B15 2SQ', 'city': 'Edgbaston, Birmingham', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site'}, {'zip': 'M15 6SX', 'city': 'Manchester', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site', 'geoPoint': {'lat': 53.48095, 'lon': -2.23743}}, {'zip': 'L22 0LG', 'city': 'Waterloo, Liverpool', 'country': 'United Kingdom', 'facility': 'GSK Investigational Site'}, {'facility': 'GSK Investigational Site'}], 'overallOfficials': [{'name': 'GSK Clinical Trials', 'role': 'STUDY_DIRECTOR', 'affiliation': 'GlaxoSmithKline'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'GlaxoSmithKline', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}